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1 Summary 
 
Zn2+, Mg2+ and Ca2+ are essential divalent cations, which are required for many signaling pathways 
and metabolic processes. Previously, different types of ion channels and transporters have been 
proposed as regulators of cytoplasmic concentrations of these cations in a cell-specific mode. 
However, it remains unclear how these proteins orchestrate the organismal balance of divalent 
cations. Here, we present evidence that the kinase-coupled TRPM7 channel plays a vital role in the 
organismal balance of Zn2+, Mg2+ and Ca2+. To understand the physiological role of TRPM7, we first 
examined TRPM7-deficient cells and found that the lack of TRPM7 results in a reduced cellular 
uptake of Zn2+ and Mg2+. To elucidate the in vivo relevance of these findings, we studied several 
mouse lines carrying mutations in the Trpm7 gene. Intestinal-specific inactivation of Trpm7 
triggered profound organismal deficiencies of Zn2+, Mg2+ and Ca2+, early postnatal growth delay and 
death. In contrast, the kidney-restricted inactivation of Trpm7 caused no effect on the mineral 
homeostasis and physical appearance of mutant mice. Furthermore, global inactivation of TRPM7 
kinase did not affect the organismal balance of divalent cations, highlighting the importance of the 
channel segment rather than the kinase domain of TRPM7 in mineral homeostasis. Importantly, 
dietary supplementation by Zn2+ and Mg2+ extended the survival rate of animals lacking intestinal 
TRPM7. Taken together, our results suggest that the intestinal TRPM7 channel functions as a 
central common gatekeeper of nutritional intake of divalent cations. 
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2 Introduction 
 
2.1 The transient receptor potential (TRP) gene family 
 
Transient receptor potential (TRP) proteins belong to a large gene family of cation channels. TRP 
channels were discovered during a search for new fruit fly Drosophila melanogaster strains with 
impaired vision. Photoreceptor cells of one mutant strain showed only a transient receptor potential 
triggered by light illumination [1]. Accordingly, the affected gene was identified and entitled as 
transient receptor potential channel [2]. 
Follow-up studies discovered 28 TRP proteins in mammals, which can be subdivided into six sub-
families based on a primary amino acid sequence homology (Figure 1): TRPA (ankyrin repeats 
containing TRP channels), TRPC (canonical channels), TRPM (melastatin-related TRP channels), 
TRPML (mucolipin channels), TRPV (vanilloid receptor related channels) and TRPP (polycystin 
channels) [3].  
With a few exceptions, the channel moiety of TRP proteins consists of 6 transmembrane helices 
and intracellular C- and N-termini. TRP channels form homo- and heterotetramers [4]. The majority 
of TRP channels are plasma membrane cation channels involved in a plethora of physiological 
processes such as temperature sensation, taste- or mechanotransduction and homeostatic control 
of cellular content of divalent cations [4]. Many TRP channels are ubiquitously expressed, while 
others display tissue-specific expression patterns [4, 5]. 
 
TRPA1
TRPC4
TRPP3
TRPM1
TRPML1
TRPV1
TRPV2
TRPV4
TRPV3
TRPV5 TRPV6
TRPP2
TRPP5
TRPC5
TRPC1
TRPC3
TRPC7
TRPC6
TRPC2
TRPM3TRPM6
TRPM7
TRPM4
TRPM5
TRPM2
TRPM8
TRPML3
TRPML2
 
Figure 1: Phylogenetic tree of the mammalian TRP gene family (modified from Nilius et al., 2011 [4]).
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2.2 The transient receptor potential cation channel, subfamily M, member 7 (TRPM7) 
 
2.2.1 Structural organization and functional characteristics of TRPM7  
 
TRPM7 and its closest homologue, TRPM6, are unique TRP channels since these proteins contain 
an ion channel covalently linked to a kinase domain [6-12]. TRPM7 functions as plasma membrane 
ion channel selective for divalent cations [6, 13, 14]. It regulates many cellular processes including 
Ca2+ and Mg2+ homeostasis, cell viability, cell proliferation, cell migration and exocytosis [6, 15-20]. 
TRPM7 is an ubiquitously expressed protein [6, 14, 21, 22] and functions as a plasma membrane 
tetrameric channel, i.e. four TRPM7 subunits build a common channel pore [23] similar to other 
TRP channels [24-27]. The channel domain of TRPM7 contains 6 transmembrane helices (Figure 
2) [5]. 
The long N-terminus of TRPM7 is highly conserved among TRPM channels and displays no appar-
ent homology to other proteins. The C-terminal segment of TRPM7 contains a transient receptor 
potential (TRP) domain, a coiled-coil (CC) domain and an α-kinase substrate domain (SD) linked to 
an α-kinase domain (KD) (Figure 2). The pore-forming region is located between the 5th and the 6th 
helix [6, 14] (Figure 2). 
In some studies, it was suggested that the TRP domain plays a key role in gating of the channel 
[23, 28, 29] and that the CC domain regulates the tetrameric assembly of the TRPM7 channel [30]. 
However, a recent study with recombinant zebrafish TRPM7 (zTRPM7) showed that a truncation 
mutation prior to the CC domain did not impair a formation of the functional zTRPM7 channel [31], 
suggesting that the CC domain might not be crucial for the tetramerization of the TRPM7 channel. 
Other studies suggested that the N-terminus of TRPM7 may be involved in tetrameric assembly of 
the channel [10]. The SD domain of TRPM7 contains multiple autophosphorylation serine and thre-
onine residues [32-34]. SD is located upstream of the kinase domain. Recently, a cryo-electron 
microscopy (cryo-EM) structure of TRPM7 was published [23]. The resolved structure confirmed 
the tetrameric assembly of TRPM7 and allowed to elucidate mechanisms of divalent cation selec-
tivity of the TRPM7 channel. It was proposed that backbone carbonyls of Phe1045, Gly1046 and 
Glu1047 form a cation selectivity filter by replacing the water molecules of the second hydration 
shell of Mg2+ entering the channel pore. 
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Figure 2: Topology of domains in the TRPM7 channel subunit. TRPM7 contains six transmembrane 
helices (1-6) and large cytosolic N- and C-termini. The C-terminus contains a highly conserved transient 
receptor potential (TRP) domain, a coiled-coil (CC) domain, a kinase substrate domain (SD) and a kinase 
domain (KD). The red dot indicates the location of the “kinase-dead” mutation K1646R. 
 
Patch-clamp experiments showed that the TRPM7 channel is selective for divalent cations [6, 13] 
displaying the permeability sequence Zn2+ ≈ Ni2+ >> Ba2+ > Co2+ > Mg2+ ≥ Mn2+ ≥ Sr2+ ≥ Cd2+ ≥ Ca2+. 
However, TRPM7 is impermeable for trivalent ions like La3+ or Gd3+ [13]. TRPM7 is able to conduct 
monovalent cations if cells are exposed to a divalent cation-free external solution. In addition, acidic 
extracellular pH reduces TRPM7’s pore permeability for Mg2+ and Ca2+ [35]. Intracellular Mg2+ and 
Mg·ATP are negative modulators of the TRPM7 channel. Consequently, it was suggested that 
metabolic processes linked to cytosolic levels of Mg2+ or Mg·ATP can regulate TRPM7 currents [6, 
36, 37]. Moreover, opening of the TRPM7 channel is controlled by the plasma membrane 
phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) [38]. 
The kinase domain of TRPM7 belongs to a family of atypical α-kinases named after their ability to 
phosphorylate serine and threonine residues located in α-helixes. Six mammalian α-kinases are 
known [39] including TRPM6 and TRPM7. Catalytic domains of α-kinases have no significant 
amino-acid sequence homology to conventional protein kinases [40]. However, a catalytic segment 
of TRPM7 kinase displays 3D similarity to that in conventional protein kinases [23, 41]. 
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2.2.2 A role of TRPM7 uncovered in cultured cells 
 
Several independent groups proposed that TRPM7 is crucial for maintaining cellular Mg2+ levels 
(Figure 3). Mg2+ is the most abundant divalent cation in the cell. Total cellular levels of Mg2+ were 
found in the range of 10-30 mM. However, free Mg2+ was estimated in the range of 0.5-1.2 mM 
since most of Mg2+ is bound to ATP, polynucleotides or ribosomes [42]. Mg2+ is crucial for many 
cellular processes. Thus, Mg2+ is a co-factor of ~600 enzyme reactions and is essential for folding 
of DNA, mRNA, tRNA and many proteins [42]. Consequently, Mg2+ deficiency results in growth 
arrest of cells [42].  
Cell lines with loss-of-function mutations in TRPM7 (TRPM7 KO) were extensively studied including 
chicken B lymphoma DT-40 cells [17], mouse embryonic stem cells [43], trophoblast stem cells [6, 
44] and human haploid leukemia (HAP1) cells [44]. All these cell lines displayed a growth arrest 
when cultured in a regular cell culture medium [44]. However, addition of Mg2+ (10 mM MgCl2) to 
the medium normalized proliferation of TRPM7-deficient cells arguing that TRPM7 is required for 
maintaining cellular Mg2+ levels [17, 43, 44]. 
 
Orai1/2Ca2+
ER
TRPM7 Zn2+
M7V
Mg2+ TRPM7
TRPM7
TRPM7 kinase phosphorylates STIM2
Mg2+ uptake
by TRPM7
TRPM7 dependent
release of Zn2+
STIM2
 
Figure 3: The suggested role of TRPM7 in regulation of cellular levels of Mg
2+
, Ca
2+
 and Zn
2+
. Cellular 
Mg
2+
 uptake is directly mediated by the TRPM7 channel. TRPM7 kinase regulates cytoplasmic Ca
2+
 levels 
indirectly due to phosphorylation of stromal interaction molecule (STIM2) located in the endoplasmic 
reticulum (ER) resulting in interaction of STIM2 with Orai1/2 channels followed by store-operated Ca
2+
 entry 
(SOCE). Intracellularly located TRPM7 modulates release of Zn
2+
 from glutathione-enriched vesicles (entitled 
as M7V). 
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Many investigators proposed that TRPM7 functions as a Ca2+ permeable channel involved in Ca2+-
signaling [6, 13, 14]. In addition, it was found that TRPM7 modulates store-operated Ca2+ entry 
(SOCE) by interaction with the endoplasmic reticulum (ER) Ca2+ sensor stromal interaction 
molecule 2 (STIM2) (Figure 3). In turn, STIM2 activates the plasma calcium release-activated 
calcium channel protein 1/2 (Orai1/2) [45, 46]. Moreover, TRPM7 was linked to cytoplasmic Ca2+ 
oscillations in eggs during the fertilization-induced early embryonic development [19, 20]. Finally, 
TRPM7 was linked to Ca2+ flicker activity in human embryonic lung fibroblasts [47]. It was proposed 
that TRPM7 can influence Ca2+ flickering due to its interaction with phospholipase C [38]. 
More recently, it was shown that TRPM7 can also regulate cellular Zn2+ levels. The group of David 
Clapham presented evidence that TRPM7 is localized in a new type of acidic glutathione (GSH)-
enriched vesicles (referred to M7V). M7V contains high Zn2+ levels and may function as intracellular 
Zn2+ stores. It was suggested that TRPM7 regulates a release of Zn2+ from these organelles to 
control cytosolic Zn2+ concentrations (Figure 3) [48]. The same study suggested that TRPM7 
activity is linked to reactive oxygen species (ROS). Specifically, ROS can trigger the TRPM7-
dependent release of Zn2+ from M7V vesicles, whereas GSH blocks TRPM7-dependent cytosolic 
Zn2+ uptake in M7V vesicles. The authors concluded that TRPM7 can function as a sensor of 
oxidative stress and controls ROS-dependent release of Zn2+ from M7V vesicles [48]. In another 
study, it was reported that TRPM7 can regulate cytosolic Zn2+ concentrations in murine embryonic 
stem cells [49]. In addition, it was shown that stress hormones increase neurotoxicity of Zn2+ due to 
increased uptake of Zn2+ via TRPM7 in neuroblastoma SH-SY5Y cells [50]. 
TRPM7 kinase phosphorylates Ser and Thr residues in a Mg2+-dependent mode [51]. Several 
substrates of TRPM7 kinase have been identified. Annexin1 is phosphorylated by TRPM7 [52]. 
Annexin1 regulates membrane fusion and its TRPM7-dependent modification may play a role in 
cell growth and apoptosis [52, 53]. Moreover, TRPM7 kinase was linked to cell motility and 
adhesion because of its ability to phosphorylate myosin IIA, IIB and IIC [54-56]. The group of David 
Clapham reported that the kinase domain of TRPM7 can be cleaved from the channel subunit and 
that the cleaved product can translocate to the cell nucleus where it interacts and phosphorylates 
the chromatin-remodeling proteins such as histone H3 [49]. Moreover, it was shown that TRPM7 
can phosphorylate PLCγ2 and, consequently, modulate PLCγ2 signaling [57]. It was suggested that 
TRPM7 kinase is able to phosphorylate eukaryotic elongation factor 2 kinase (eEF2K) leading to 
changes in protein translation rate in cells challenged by Mg2+ starvation [58]. In addition, there are 
several TRPM7 autophosphorylation residues, which may modulate channel activity and trafficking 
of TRPM7 [34]. The functional relationship of the kinase and channel moieties of TRPM7 was 
extensively studied but it remains not well understood. To elucidate such interaction, different point 
mutations were introduced in TRPM7 diminishing its kinase activity referred to as ‘kinase-dead’ 
TRPM7 variants. The ‘kinase-dead’ mutation K148R was found to be able to negatively regulate 
TRPM7 currents [14, 17]. In contrary, other studies showed that activity of TRPM7 kinase did not 
modify the channel features of TRPM7 including its sensitivity to intracellular Mg2+ [33]. 
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2.2.3 Assessment of TRPM7 in genetic animal models 
 
To elucidate the in vivo role of TRPM7, several animal genetic models have been produced by 
independent groups. Thus, Jin et al. generated a mouse strain with a global deletion of TRPM7 
[59]. First, a mouse line with two loxP sites flanking exon 17 of TRPM7 was produced. Next, these 
mice were crossed with transgenic mice ubiquitously expressing Cre recombinase from Sox2-Cre 
transgene. This cross resulted in a global null mutation in Trpm7 (Trpm7 null/null) because the 
deletion of exon 17 introduces a frame-shift mutation in the open reading frame (ORF) of Trpm7. 
Trpm7 null/null individuals were not able to survive after embryonic day 6.5 (e6.5) [59] indicating that 
TRPM7 is essential for the early embryonal development (Table 1). The underlying mechanisms of 
this phenotype remain unknown.  
In another study, Ryazanova et al. replaced exons 32-36 of Trpm7 with a neomycin resistance 
sequence resulting in a truncation of TRPM7 upstream of the α-kinase domain [43]. Mice 
homozygous for Trpm7 Δkinase (Trpm7 Δkinase/Δkinase) showed early embryonic lethality at e8.5 (Table 1) 
(similar to the phenotype of Trpm7 null/null mice [59]) suggesting that Trpm7 Δkinase is also a null 
mutation. In contrast to the Trpm7 Δkinase/Δkinase animals, heterozygous mice (Trpm7 Δkinase/wt) were 
viable (Table 1). Trpm7 Δkinase/wt mice developed no signs of Mg2+ deficiency if maintained on a 
regular diet containing 0.1% Mg2+. However, mutant mice fed by a low Mg2+ diet (0.003%) displayed 
reduced Mg2+ levels in serum and bones, and increased mortality compared to wildtype mice 
placed on the same Mg2+-deficient diet. Consistently, Mg2+ content in feces of Trpm7 Δkinase/wt was 
increased. The authors suggested that Trpm7 Δkinase/wt mice develop a defect in Mg2+ absorption in 
the intestine [43]. 
To define a role of TRPM7 in the morphogenesis of embryonic organs, a set of Cre transgenes 
were explored for a conditional tissue-specific inactivation of Trpm7 (Table 1). Thus, deletion of 
Trpm7 in T cell lineage led to impaired thymopoiesis [59]. Knock out of TRPM7 in the metanephric 
mesenchyme of the kidney resulted in abnormal kidney development [60] indicating that TRPM7 is 
required for nephrogenesis. Additionally, TRPM7 was found to be involved in cardiac development 
because a heart-specific deletion of TRPM7 at e9 resulted in heart failure and death [61]. A deletion 
of TRPM7 in the embryonic myocardium or the sinoatrial node revealed a key role of TRPM7 in 
cardiac automaticity [62]. Inactivation of TRPM7 in megakaryocytes resulted in reduced Mg2+ in 
platelets, macrothrombocytopenia and thrombocytopenia [63].  
While a global disruption of TRPM7 using tamoxifen-inducible Cre transgene at e7-9 caused 
prenatal death, a loss of TRPM7 at e14.5 or in 4-6 weeks old mice did not impact viability and 
physical appearance of the mutants [60]. However, it is well documented that a tamoxifen-inducible 
deletion of floxed alleles may be incomplete especially in differentiated cells or in tissues with a 
high cellular renewal rate. Hence, additional mice strains with a well-controlled tissue-specific 
ablation of TRPM7 may provide new information about the role of TRPM7 in the adult organism. 
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Table 1: Published mice strains carrying mutations in Trpm7 
Name of strain  Effect on Trpm7  Phenotype 
Trpm7 Δkinase/Δkinase [43] Global null mutation Mortality at e8.5 
Trpm7 Δkinase/wt [43] 
Heterozygote for global null 
mutation 
Systemic Mg2+ deficiency induced by 
a low Mg2+ diet 
Trpm7 null/null [59] Global null mutation Mortality at e6.5 
Trpm7 ki/ki [64-66] Global kinase-dead mutation 
Normal overall appearance and 
behavior; slightly affected Mg2+ 
homeostasis; altered immune system 
homoeostasis  
Trpm7 fl/fl; Lck-Cre [59] 
Deletion of TRPM7 in developing 
thymocytes 
Impaired thymopoiesis 
Trpm7 fl/fl; Mb1-Cre [67] Deletion of TRPM7 in B cells 
Blocked development of mature 
peripheral B cells 
Trpm7 fl/fl; Pf4-Cre [63] 
Deletion of TRPM7 in 
megakaryocytes 
Reduced Mg2+ in platelets, 
macrothrombocytopenia, 
thrombocytopenia 
Trpm7 fl/fl; Pax3-Cre [60] 
Deletion of TRPM7 in the 
metanephric mesenchyme of the 
embryonic kidney at e11.5 
Abnormal kidney development 
Trpm7 fl/fl; TnT-Cre [61] Deletion of TRPM7 in the heart at 
<e9 
Heart failure and death at e11.5 
Trpm7 fl/fl; 
αMHC-Cre [61, 62] 
Deletion of TRPM7 in the heart at 
e13 
Impaired cardiac automaticity in adult 
mice 
Trpm7 fl/fl; HCN4-
CreERT2 [62] 
Tamoxifen-inducible deletion of 
TRPM7 the sinoatrial node at e9 
Affected cardiac automaticity in adult 
mice 
Trpm7 fl/fl; Cre-ER [60] 
Tamoxifen-inducible deletion at 
e14.5 or in 4-6 weeks old mice 
No obvious effect 
 
 
More recently, two groups [65, 66] generated mice with the kinase-dead K1646R point mutation in 
the Trpm7 gene (Trpm7 ki/ki) (Figure 2). The kinase-dead mice developed normally and showed no 
noticeable changes in physical appearance and behavior [65]. However, challenged Trpm7 ki/ki mice 
developed an altered immune system homeostasis limiting the differentiation of T cells along the 
TH17 functional program (Table 1) [64]. Serum Mg
2+ and Ca2+ concentrations were not altered in 
Trpm7 ki/ki mice [65]. In another study [66], an independent kinase-dead mouse line was produced 
using the same point mutation. These mutants were also viable and showed no pathophysiological 
changes. However, the authors found that bone Mg2+ content was ~15% reduced in 6 months old 
animals whereas serum Mg2+ concentrations were normal.  
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To summarize, TRPM7 plays a key role in early embryonic development and morphogenesis of 
internal organs of mice. Moreover, TRPM7 is likely involved in regulation of systemic homeostasis 
of Mg2+. Mechanistically, the in vivo role of TRPM7 remains not fully understood. 
 
 
2.2.4 A role of TRPM7 in macrothrombocytopenia 
 
Recently, a genome sequencing of 702 patients with platelet disorders was performed [63] resulting 
in a discovery of patients carrying point mutations in the TRPM7 gene. Specifically, families 
harboring C721G and R902C mutations in TRPM7 were identified. Both mutations are located in 
the channel segment of TRPM7. In vitro studies of recombinant C721G and R902C TRPM7 
variants revealed a reduction of TRPM7 currents (85% and 39%, respectively). The affected 
patients were heterozygous for C721G and R902C and exhibited low platelet counts and 
macrothrombocytopenia associated with alterations in cytoskeletal architecture. Follow-up studies 
with the patients carrying a C721G mutation revealed that Mg2+ levels were low in the platelets. In 
addition, the affected subject developed atrial fibrillation. Platelets from all C721G patients 
displayed an increased cell size, exhibited a spherical shape and contained multiple vacuoles as 
well as an abnormal cytoskeletal organization. The authors suggested that abnormal Mg2+ balance 
in platelets underlies macrothrombocytopenia, similarly to Mg2+ deficient platelets of Trpm7 fl/fl; Pf4 
mice (Table 1). 
 
 
2.3 A role of ion channels and transporters in organismal balance of Ca2+, Mg2+ and Zn2+  
 
2.3.1 Maintenance of systemic Mg2+ homeostasis 
 
Mg2+ is the most abundant divalent cation in the cell and is required for a wide range of cellular 
processes. Mg2+ is a cofactor of over 600 enzymatic reactions [42, 68-70]. Inadequate cellular Mg2+ 
uptake negatively impacts the synthesis and stability of proteins, impairs energy metabolism and, 
consequently, blocks cell proliferation [17, 71-73]. The major storage depots of Mg2+ are bones 
(containing 50-60% of body Mg2+) and skeletal muscles (comprising 25-30% of total Mg2+) [42]. The 
concentration of Mg2+ in the serum is tightly controlled in the range of 0.7-1.1 mM [74]. Hormones 
or metabolites, which specifically regulate systemic Mg2+ homeostasis, are not known. 
Organismal balance of Mg2+ is maintained by intestinal absorption and renal excretion [75]. In the 
kidney, more than 95% of Mg2+ is reabsorbed from the primary urine [75]. In general, epithelial 
transport of divalent cations occurs by an active (transcellular) and a passive (paracellular) process 
(Figure 4). In the paracellular pathway, cations are passed through an epithelial layer via the tight 
junctions. The active transcellular transport consists of three steps: (1) apical uptake of cations by 
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channels or transporters; (2) cytosolic transport of cations by carrier proteins; (3) basolateral 
excretion of cations by transporters or exchangers (Figure 4). 
 
apical basolateral
Mg2+
paracellular (passive)
route
transcellular (active)
route
Ca2+
Zn2+
Trpm6/7
Trpv5/6
Zip4
Claudin
Claudin
Ca2+
D9k/D28k
Slc41a1/2/3
Cnnm4
NCX /
PMCA1b/4
ZnT1/4
Mg2+
Zn2+
MT1
D9k/D28k
Mg2+
Ca2+
Zn2+
 
Figure 4: Key players involved in the transport of divalent cations in the kidney and the intestine. The 
paracellular pathway occurs via tight junctions formed by claudins (claudin-16 and 19 for Mg
2+
 and claudin-2, 
12, 14, 15, 16 and 19 for Ca
2+
). The transcellular pathway is driven by apical uptake of divalent cations 
mediated by channels and transporters such as Trpm6/7 (for Mg
2+
), Trpv5/6 (for Ca
2+
) and Zip4 (for Zn
2+
). 
Several carrier proteins such as calbindin-D9k/D28k (for Ca
2+
 and Mg
2+
) and MT1 (for Zn
2+
) deliver divalent 
cations to the basolateral cell surface. Slc41a1, Slc41a2, Slc41a3 and Cnnm4 (for Mg
2+
), NCX and PMCA1b/ 
PMCA4 (for Ca
2+
) and ZnT1/4 (for Zn
2+
) are responsible for extrusion of divalent cations. 
 
 
In the kidney, 90% of Mg2+ reabsorption occurs in the thick ascending limb via the paracellular 
pathway. Only 10% of Mg2+ is reabsorbed in the distal convoluted tubule (DCT) by the transcellular 
route. Mg2+ reuptake was undetectable in nephron segments distal to DCT [76, 77]. Therefore, it 
was suggested that DCT controls the final urinary Mg2+ content and thereby regulates the whole 
body balance of Mg2+ [76, 77]. The transcellular transport of Mg2+ occurs via tight junction proteins 
formed by claudin-16 and claudin-19 and is driven by the positive electrical potential of the lumen 
[75, 78-83]. 
In the transcellular pathway, the apically located Mg2+ channel TRPM6 was proposed to drive an 
apical Mg2+ entry in DCT [8, 84]. However, a recent study of our group demonstrated that genetic 
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inactivation of Trpm6 in the kidney has a rather minor impact in this process [44]. A role of TRPM7 
in renal reabsorption was extensively discussed in the literature [10, 44], but this concept has not 
been addressed yet in animal genetic models. Calbindin-D9k and -D28k were discussed as 
possible intracellular carriers; however, the in vivo evidence in favor of this concept is missing [85, 
86]. Slc41a3 may be involved in the basolateral extrusion step [87]. In accordance, Slc41a3 KO 
mice had decreased Mg2+ serum levels. 
In the intestine, both para- and transcellular mechanisms operate to control the nutritional intake of 
Mg2+. Both TRPM6 and TRPM7 were identified in intestinal enterocytes [44, 88] (Figure 4) and 
were suggested as prime players in the uptake of luminal Mg2+. A recent study of our laboratory has 
shown that global or intestine-specific ablation of Trpm6 causes a systemic Mg2+ deficit in mice. 
However, a particular in vivo role of Trpm7 and other genes remains to be established. Several 
proteins were suggested to play a role in the basolateral extrusion of Mg2+ in the intestine including 
Slc41a1, Slc41a2, Slc41a3 and Cnnm4 (Figure 4) [87, 89-94]. Consistently, Slc41a3 and Cnnm4 
KO mice displayed reduced serum Mg2+ concentrations [87, 94]. 
 
 
2.3.2 Regulation of Ca2+ balance in vivo 
 
Ca2+ is an essential divalent cation, which is required for many fundamental physiological 
processes [95]. Apart from the intestine and the kidney, bones play an important role in organismal 
Ca2+ balance since this tissue stores 99% of body Ca2+ [96, 97]. The concentration of Ca2+ in the 
serum is maintained in the range of 2.2–2.7 mM. Parathyroid hormone (PTH) and an active form of 
vitamin D (1,25-(OH)2D3) are well-known factors regulating circulating Ca
2+ concentrations [97, 98]. 
When serum Ca2+ is reduced, PTH is released from parathyroid gland to the circulation system, 
what leads to enhanced production of 1,25-(OH)2D3 by the kidney [99]. 1,25-(OH)2D3 regulates 
Ca2+ uptake in the intestinal and renal epithelial cells acting as a transcriptional regulator of Ca2+ 
channels and transporters. 
In the kidney, reabsorption of Ca2+ takes place primarily in the proximal tubule and in the thin 
ascending loop via the paracellular pathway build up by claudins-14, 16 and 19 (Figure 4) [98, 100, 
101]. DCT maintains the transcellular transport of Ca2+. Similar to Mg2+, it was suggested that this 
process in DCT determines the urinary excretion rate of Ca2+. In DCT, apical entry of Ca2+ is 
mediated by the TRPV5 channel (Figure 4). Trpv5 KO mice displayed an increased renal excretion 
rate of Ca2+ [102]. Surprisingly, Ca2+ serum levels were not altered in Trpv5 KO mice. Cytosolic 
Ca2+ was proposed to be carried out by calbindin-D28k and extruded by basolateral Na+/Ca2+ 
exchanger (NCX) or plasma membrane Ca2+ ATPase 4 (PMCA4) (Figure 4) [103-106]. 
The Ca2+ selective TRPV6 channel was suggested as the main contributor for intestinal uptake of 
Ca2+ (Figure 4) [107]. TRPV6 was found to be located at the apical surface of intestinal enterocytes 
[108]. In addition, transcription of Trpv6 is positively regulated by 1,25-(OH)2D3 or low dietary Ca
2+ 
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treatment [102, 109] and is stimulated by 1,25-(OH)2D3 [110-112]. However, Trpv6 KO mice were 
viable, had normal Ca2+ serum levels and showed only a weak increase in serum PTH and 
1,25-(OH)2D3. Moreover, further experiments with mouse models could not confirm a concept that 
TRPV6 is the gatekeeper of nutritional uptake of Ca2+ [113, 114]. 
Taken together, several ion channels and transporters have been suggested to play a critical role in 
1,25-(OH)2D3 sensitive transport of Ca
2+ in the kidney and intestine. However, the main route for 
apical uptake remains elusive. 
 
 
2.3.3 Systemic Zn2+ homeostasis 
 
Zn2+ is a vital trace element required for many cellular pathways [115, 116]. The World Health 
Organization (WHO) estimates that 800.000 deaths per year worldwide were due to insufficient 
nutritional intake of Zn2+ [116]. In the body, Zn2+ is mainly stored in skeletal muscles (60% of total 
body Zn2+) and bones (30% of all Zn2+) [115]. The concentration of Zn2+ in the serum is maintained 
in the range of 17-19 µM [115]. Hormones involved in organismal homeostasis of Zn2+ remain to be 
established. The kidney appears to play a minor role in body balance of Zn2+ [117, 118]. The small 
intestine (particularly duodenum) primarily controls both absorption and excretion of Zn2+ [119-121]. 
Zn2+ absorption takes place through trans- and paracellular routes [121]. 
The cellular balance of Zn2+ is thought to be regulated by Zn2+ transporters of two gene families 
[115]. Zinc transporter (ZnT, SLC30 family, ZnT1-10) reduce cytosolic Zn2+ levels by promoting Zn2+ 
efflux to extracellular space or entry of Zn2+ in intracellular vesicles, ER or mitochondria. Zip 
transporters (SLC39 family, Zip1-14) increase cytosolic Zn2+ concentrations by facilitating uptake of 
extracellular Zn2+ or by release of Zn2+ from intracellular membrane compartments [115]. Several of 
these ZnT and Zip genes are highly expressed in the small intestine [115]. However, the genetic 
evidence is available only for Zip4, ZnT1 and ZnT4. Thus, it was proposed that Zip4 mediates 
uptake of luminal Zn2+ [122, 123]. Cytosolic Zn2+ is likely bound to the carrier protein 
metallothionein 1 (MT1) [124, 125] and extruded at the basolateral side by ZnT1 and/or ZnT4 [126, 
127] (Figure 4). 
Mutations in the human Zip4 gene result in the disease “acrodermatitis enteropathica” (AE) 
characterized by a defective intestinal Zn2+ absorption [122, 128, 129]. The breastfed human 
infants lacking Zip4 are asymptomatic, but soon after weaning the affected subjects develop signs 
of Zn2+ deficiency including alopecia, dermatitis, diarrhea, growth retardation and many other 
symptoms. AE can be fatal unless the patients are not supplemented by Zn2+ [129]. Consistently, 
only weaned mice with conditional intestine-specific inactivation of Zip4 start to develop an 
imbalance in Zn2+ homeostasis [130, 131], likely due to increased bioavailability of Zn2+ in breast 
milk [132]. Therefore it was suggested that additional transporters are capable to mediate Zn2+ 
uptake in the absence of Zip4 [133]. 
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3 Aims 
 
Currently, the physiological role of the kinase-coupled channel TRPM7 is surrounded by consider-
able controversy. In a previous study of our laboratory, the kidney- and intestine-specific mutagen-
esis of a genetically related channel-kinase, TRPM6, in mice enabled to define the physiological 
role of TRPM6 [44]. Thus, it was demonstrated that TRPM6 operates in the placenta and intestine 
to maintain organismal Mg2+ balance. 
 
Accordingly, the present project aims to provide answers to key questions about the in vivo roles of 
kinase-coupled TRPM7 channels using cells deficient in TRPM7 and mice strains with a tissue-
specific ablation of TRPM7. Specifically, the project aimed to address the following pertinent ques-
tions: 
 
(1) What is the role of TRPM7 in cellular uptake of divalent cations? 
 
(2) What is the role of TRPM7 for the reabsorption of divalent cations in the kidney? 
 
(3) What is the role of TRPM7 for the absorption of divalent cations in the intestine?  
 
(4) What is the role of TRPM7 kinase in pre- and postnatal growth and survival as well as the 
maintenance of mineral and tissue homeostasis? 
   4 Materials 
  
19 
4 Materials 
 
4.1 Chemicals 
 
Table 2: List of reagents used in the present study 
Chemicals Source 
10mM dNTP Mix PCR Grade Astral-Scientific, Taren Point, Australia 
10x DIG RNA Labeling Mix Roche, Rotkreuz, Switzerland 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) 
Sigma-Aldrich, St. Louis, USA 
5x Transcription buffer Roche, Penzberg, Germany 
65ZnCl2 (0.5 M HCl) Perkin Elmer, Waltham, USA 
Acetic acid 99% Merck, Darmstadt, Germany 
Acetic anhydride  Sigma-Aldrich, St. Louis, USA 
Agarose (NEEO ultra quality) Carl Roth, Karlsruhe, Germany 
Agarose (Standard) Sigma-Aldrich, St. Louis, USA 
Anti-DIG-AP antibody Roche, Rotkreuz, Switzerland 
BCIP (5-bromo-4-chloro-3-indolyl-phosphate) Promega, Madison, USA 
Bovine serum albumin (BSA) >96% Sigma-Aldrich, St. Louis, USA 
Calcium chloride dihydrate (CaCl2 * 2 H2O) Sigma-Aldrich, St. Louis, USA 
Dako fluorescent mounting medium Agilent Dako, California, USA 
Diethylpyrocarbonate (DEPC) Sigma-Aldrich, St. Louis, USA 
Dithiothreitol (DTT) Roth, Karlsruhe, Germany 
DNA Gel Loading Dye (6X) Sigma-Aldrich, St. Louis, USA 
DPX mounting medium Sigma-Aldrich, St. Louis, USA 
Eosin G solution Diapath, Martinengo, Italy 
Ethanol 100% (EtOH) Sigma-Aldrich, St. Louis, USA 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, St. Louis, USA 
Ethylenediaminetetraacetic acid disodium salt 
dihydrate (Na2EDTA * 2 H2O) 
Roth, Karlsruhe, Germany 
Fetal bovine serum (FBS) 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Ficoll 400 Sigma-Aldrich, St. Louis, USA 
Formamide (100%) Sigma-Aldrich, St. Louis, USA 
Formamide (50%, hybridization cocktail) Amresco, Solon, USA 
GeneRuler 100 bp DNA Ladder 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
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Glucose Sigma-Aldrich, St. Louis, USA 
Glycerol (steril) Sigma-Aldrich, St. Louis, USA 
Goat anti-rabbit antibody Alexa Fluor 488  ife Technologies   Carlsbad, USA 
Goat serum (heat inactivated) Sigma-Aldrich, St. Louis, USA 
Hoechst 33342  ife Technologies   Carlsbad, USA 
Hydrochloric acid (HCl) (37%) Merck, Darmstadt, Germany 
Isoflurane (100%) Ecuphar GmbH, Greifswald, Germany 
Jung tissue freezing medium Leica Microystems GmbH, Nussloch, Germany 
Lambda-Carrageenan Sigma-Aldrich, St. Louis, USA 
Levamisole Sigma-Aldrich, St. Louis, USA 
Lithium chloride (LiCl) Sigma-Aldrich, St. Louis, USA 
Magnesium chloride hexahydrate 
(MgCl2 * 6 H2O) 
Sigma-Aldrich, St. Louis, USA 
Maleic acid (100%) Sigma-Aldrich, St. Louis, USA 
Mayer’s hematoxylin solution Diapath, Martinengo, Italy 
NBT (nitro blue tetrazolium) Color Substrate  
(50 mg/ml) 
Promega, Madison, USA 
Nuclear Fast Red Sigma-Aldrich, St. Louis, USA 
Nuclease-free water 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
O’GeneRuler  ow Range DNA  adder 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Paraffin Sigma-Aldrich, St. Louis, USA 
Paraformaldehyde (PFA) Sigma-Aldrich, St. Louis, USA 
Paraformaldehyde 16% in 1x PBS (16% PFA) 
Electron Microscopy Sciences, Hatfield, United 
Kingdom 
Penicillin-Streptomycin (10.000 units penicillin, 
10 mg streptomycin/ml)  
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Phosphate-buffered saline (PBS  Dulbecco’s 
Phosphate Buffered Saline) 
Sigma-Aldrich, St. Louis, USA 
Polyvinylpyrrolidone (PVP) Sigma-Aldrich, St. Louis, USA 
Potassium chloride (KCl) Sigma-Aldrich, St. Louis, USA 
Potassium dihydrogen phosphate (KH2PO4) Roth, Karlsruhe, Germany 
Potassium hydroxide (KOH) Roth, Karlsruhe, Germany 
Rabbit anti-TRPM7 antibody AB15562 Millipore   Billerica, USA 
RNAlater RNA Stabilization Reagent Qiagen, Hilden, Germany 
Roche Blocking Reagent Roche, Penzberg, Germany 
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Roti GelStain Roth, Karlsruhe, Germany 
Rotiszint Roth, Karlsruhe, Germany 
Sodium acetate (C2H3NaO2) Sigma-Aldrich, St. Louis, USA 
Sodium acid (NaN3) Sigma-Aldrich, St. Louis, USA 
Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodium citrate dihydrate (Na3C6H5O7 * 2 H2O) Merck, Darmstadt, Germany 
Sodium dextran sulfate Sigma-Aldrich, St. Louis, USA 
Sodium dihydrogen phosphate dihydrate 
(NaH2PO4 * 2 H2O) 
Roth, Karlsruhe, Germany 
Sodium hydrogen phosphate dihydrate 
(Na2HPO4 * 2 H2O) 
Roth, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Merck, Darmstadt, Germany 
Sucrose Sigma-Aldrich, St. Louis, USA 
TMAC (Tetramethyl ammonium chloride) Sigma-Aldrich, St. Louis, USA 
Triethanolamine Sigma-Aldrich, St. Louis, USA 
Tris (2-Amino-2-hydroxymethyl-propane-1,3-
diol) 
Roth, Karlsruhe, Germany 
Tris HCl (2-Amino-2-hydroxymethyl-propane-
1,3-diol hydrochloride) 
Sigma-Aldrich, St. Louis, USA 
Triton X-100 Sigma-Aldrich, St. Louis, USA 
tRNA from baker’s yeast Roche, Penzberg, Germany 
Trypsin-EDTA solution Sigma-Aldrich, St. Louis, USA 
Tween 20 Sigma-Aldrich, St. Louis, USA 
Xylene Sigma-Aldrich, St. Louis, USA 
Zinc sulfate heptahydrate (ZnSO4 * 7 H2O) Sigma-Aldrich, St. Louis, USA 
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4.2 PCR primers 
 
All primers were acquired at Metabion, Planegg-Martinsried, Germany. 
 
Table 3: Primers used for genotyping of mouse strains 
Name Sequence Amplicon 
Ksp1.3-Cre for 5`-GCA GAT CTG GCT CTC CAA AG-3` 
420 bp 
Ksp1.3-Cre rev 5`-AGG CAA ATT TTG GTG TAC GG-3` 
Trpm7 ki for 5`-AAT GGG AGG TGG TTT ACG-3` 
195 bp 
Trpm7 ki rev 5`-CTC AGA TCA CAG CTT ACA GTC A-3` 
Trpm7 wt for 5`-TCT GAG CTA AAA GTA TGA AGT C-3` 336 bp (wt); 
446 bp (fl) Trpm7 wt rev 5`-ATA CCA CAA AAT CTC TGC CCT CTA A-3` 
Villin1-Cre for 5`-CAT GTC CAT CAG GTT CTT GC-3` 
205 bp 
Villin1-Cre rev 5`-TTC TCC TCT AGG CTC GTC CA-3` 
 
 
Table 4: Primers used for qRT-PCR analyses 
Name Sequence Amplicon 
Abcc1 for 5`-GGA CAA GGT GGA GGG ACA T-3` 
84 bp 
Abcc1 rev 5`-CGG AGA GAG TCA TTC TGA ATC C-3` 
Abcc2 for 5`-TTT CCT GGA TTA CCT CCA ACC-3` 
76 bp 
Abcc2 rev 5`-GCC GAG CAG AAG ACA ATC A-3` 
Calbindin-D9k for 5`-CCT GCA GAA ATG AAG AGC ATT TT-3` 
175 bp 
Calbindin-D9k rev 5`-CTC CAT CGC CAT TCT TAT CCA-3` 
Claudin-16 for 5`-GGT TGC TTT TTG GCA GGA-3` 
74 bp 
Claudin-16 rev 5`-TAG TTC CTC TCA GGC CCA AC-3` 
Cyp27b1 for 5`-AGT GGG GAA TGT GAC AGA GC-3` 
61 bp 
Cyp27b1 rev 5`-GGA GAG CGT ATT GGA TAC CG-3` 
Dclk1 for 5`-TCT GTG GCA CCC CAA CAT A-3` 
66 bp 
Dclk1 rev 5`-CCA CCT TGA GGC CAT ATC C-3` 
Gclc for 5`-AGA TGA TAG AAC ACG GGA GGA G-3` 
62 bp 
Gclc rev 5`-TGA TCC TAA AGC GAT TGT TCT TC-3` 
Gpx2 for 5`-GTT CTC GGC TTC CCT TGC-3` 
64 bp 
Gpx2 rev 5`-TCA GGA TCT CCT CGT TCT GAC-3` 
Gss for 5`-TGT CCA ATA ACC CCA GCA AG-3` 
87 bp 
Gss rev 5`-TCA GTA GCA CCA CCG CAT T-3` 
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Gsr for 5`-ACT ATG ACA ACA TCC CTA CTG TGG-3` 
89 bp 
Gsr rev 5`-CCC ATA CTT ATG AAC AGC TTC GT-3` 
Gsta1 for 5`-CTT CTG ACC CCT TTC CCT CT-3` 
87 bp 
Gsta1 rev 5`-GCT GCC AGG CTG TAG GAA C-3` 
Gsta2 for 5`-TCT GAC CCC TTT CCC TCT G-3` 
85 bp 
Gsta2 rev 5`-GCT GCC AGG ATG TAG GAA CT-3` 
Gsta3 for 5`-TGG ACA ACT TCC CTC TCC TG-3` 
107 bp 
Gsta3 rev 5`-TGC GTC ATC AAA AGG CTT C-3` 
Gstm1 for 5`-GCA GCT CAT CAT GCT CTG TTA-3` 
76 bp 
Gstm1 rev 5`-TTT CTC AGG GAT GGT CTT CAA-3` 
Gstm3 for 5`-TTA TGG ACA CCC GCA TAC AG-3` 
75 bp 
Gstm3 rev 5`-TCA AGA ACT CTG GCT TCT GCT-3` 
Gstp1 for 5`-TGT CAC CCT CAT CTA CAC CAA C-3` 
94 bp 
Gstp1 rev 5`-GGA CAG CAG GGT CTC AAA AG-3` 
Hprt for 5`-CTC ATG GAC TGA TTA TGG ACA GG-3` 
135 bp 
Hprt rev 5`-TTA ATG TAA TCC AGC AGG TCA GC-3` 
Lgr5 for 5`-CTG CCC ATC ACA CTG TCA CT-3` 
172 bp 
Lgr5 rev 5`-GCA GAG GCG ATG TAG GAG AC-3` 
Lrg for 5`-GGA GCA GCT ATG GTC TCT TG-3` 
125 bp 
Lrg rev 5`-AGT ATC AGG CAT TCC TTG AG-3` 
Lyz1 for 5`-GGC AAA ACC CCA AGA TCT AA-3` 
104 bp 
Lyz1 rev 5`-TCT CTC ACC ACC CTC TTT GC-3` 
Mgst2 for 5`-CGG ACG AGC AAG ACT AAA ACA-3` 
113 bp 
Mgst2 rev 5`-TGA ATA CAG GAT AAA ACT CCA AAG AG-3` 
MT1 for 5`-TGG ACC CCA ACT GCT CCT G-3` 
185 bp 
MT1 rev 5`-TCA GGC ACA GCA CGT GCA C-3` 
Muc2 for 5`-GAC CTG ACA ATG TGC CCA GA-3` 
66 bp 
Muc2 rev 5`-GGC AAA CAC AGT CCT TGC AG-3` 
Slc41a1 for 5`-CAT GGT GCT GGA CAT TGT G-3` 
109 bp 
Slc41a1 rev 5`-CAG GGT CAT TTC CAA GTT CC-3` 
Slc41a2 for 5`-GTT TAC ACG CCA GTT ATC AAC G-3` 
77 bp 
Slc41a2 rev 5`-TGG AGG TAG GTA GAA ATC CTG CT-3` 
Tff3 for 5`-GTA ACA ACC GTG GCT GCT G-3` 
103 bp 
Tff3 rev 5`-GAG CCT GGA CAG CTT CAA AA-3` 
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Trpm6 for 5`-CAC CGC TTC CTC ACC ATC-3` 
74 bp 
Trpm6 rev 5`-CGC AAA AAT TTA TTA GTT GGT CCT-3` 
Trpm7 ex. 17 for 5`-AGT AAT TCA ACC TGC CTC AA-3` 
287 bp 
Trpm7 ex. 17 rev 5`-ATG GGT ATC TCT TCT GTT ATG TT-3` 
Trpv5 for 5`-ATT GAC GGA CCT GCC AAT TAC AGA G-3` 
285 bp 
Trpv5 rev 5`-GTG TTC AAC CCG TAA GAA CCA ACG-3` 
Trpv6 for 5`-ATC GAT GGC CCT GCG AAC T-3` 
358 bp 
Trpv6 rev 5`-CAG AGT AGA GGC CAT CTT GTT GCT G-3` 
Villin1 for 5`-ATC TCC CTG AGG GTG TGG A-3` 
62 bp 
Villin1 rev 5`-AGT GAA GTC TTC GGT GGA CAG-3` 
Ywhaz for 5`-TAA AAG GTC TAA GGC CGC TTC-3` 
60 bp 
Ywhaz rev 5`-CAC CAC ACG CAC GAT GAC-3` 
Zip4 for 5`-ACT TTG TGG ACT TTG TGT TCA GG-3` 
193 bp 
Zip4 rev 5`-GAG TAT GGA GCT CAG AGT CTT GG-3` 
Zip5 for 5`-AGG ACC TAG TGA GCA ATC AGA GG-3` 
155 bp 
Zip5 rev 5`-TTC TCC AAG ATC CCT TTT GTT CC-3` 
ZnT1 for 5`-TGG ATG TAC AAG TAA ATG GGA ATC T-3` 
62 bp 
ZnT1 rev 5`-GTC TTC AGT ACA ACC CTT CCA GTT A-3` 
ZnT2 for 5`-CAG AAG GAT TCT GGA AGT CAC C-3` 
211 bp 
ZnT2 rev 5`-CGG GAA GAC ACC CAG AGG-3` 
ZnT4 for 5`-TAG GTG GAT ACA TGG CAA ATA GC-3` 
243 bp 
ZnT4 rev 5`-AGT TCA TAT GGA TGG TTC TCT GC-3` 
 
 
Table 5: Primers used to generate ISH probe 
Name Sequence 
Trpm7 ex17 for 5’-aattaaccctcactaaagggTGGCAGTTGAATTACTGGAACA-3’ 
Trpm7 ex17 rev 5’-taatacgactcactatagggTCATATTCAGCCGTCCCATC-3’ 
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4.3 Enyzmes 
 
Table 6: Enzymes with corresponding buffers used in the present study 
Enzyme Buffer Source 
Proteinase K Proteinase K buffer Roche, Rotkreuz, Switzerland 
RNA polymerase T3 Transcription buffer Roche, Rotkreuz, Switzerland 
RNA polymerase T7 Transcription buffer Roche, Rotkreuz, Switzerland 
RNase A RNA wash buffer Roche, Rotkreuz, Switzerland 
Taq DNA polymerase Standard Taq buffer Roche, Rotkreuz, Switzerland 
Tru1I DNA polymerase Buffer R 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
 
 
4.4 Buffers and solutions 
 
Table 7: 50x Tris-acetate-EDTA (pH 8.5, TAE buffer) 
Name Composition 
50x TAE 242 g Tris 
 57 ml Acetic acid (99%) 
 100 ml 0.5 M EDTA (pH 8.0) 
  pH to 8.5 with 5 M KOH 
  ad 1000 ml dH2O 
 
 
Table 8: 0.5 M EDTA (pH 8.0) 
Name Composition 
0.5 M EDTA 186 g Na2EDTA * 2 H2O 
  pH to 8.0 with 10 M NaOH 
  ad 1000 ml dH2O 
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Table 9: Villi isolation buffer A (pH 7.4) 
Name Composition 
Villi isolation buffer A 1.12 g NaCl 
 1.59 g  Na3C6H5O7 * 2 H2O 
 22.4 mg KCl 
 218 mg KH2PO4 
 401 mg Na2HPO4 * 2 H2O 
  pH to 7.4 with HCl 
  ad 200 ml dH2O 
 
 
Table 10: Villi isolation buffer B 
Name Composition 
Villi isolation buffer B 87.7 mg EDTA 
 15.4 mg DTT (freshly added before use) 
 200 mg BSA (freshly added before use) 
  ad 200 ml phosphate-buffered saline (PBS) 
 
 
Table 11: HEPES buffered saline (HBS) (pH 7.4) 
Name Composition 
HBS 30 ml 5 M NaCl 
 5.4 ml 1 M KCl 
 5 ml 1 M HEPES 
 10 ml 1 M Glucose 
 1 ml 1 M MgCl2 
 2 ml 1 M CaCl2 
  pH to 7.4 with HCl 
  ad 1000 ml dH2O 
 
 
Table 12: 4% PFA in PBS (used for histological examination of the intestine) 
Name Composition 
4% PFA 10 ml 16% PFA 
 30 ml PBS 
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Table 13: 0.4% PFA in PBS (used for histological examination of the intestine) 
Name Composition 
0.4% PFA 10 ml 4% PFA 
 90 ml PBS 
 
 
4.5 Reagents used for in situ hybridization (ISH) of mouse kidney sections 
 
Table 14: DEPC-treated water (RNase free water) 
Name Composition 
DEPC-treated water 2 l dH2O 
 1 ml 100% DEPC 
  
Stir for 2 h and incubate overnight at room 
temperature (RT), autoclave for 15 min at 121 °C 
 
 
Table 15: 20x Phosphate-buffered saline (PBS) (pH 7.5) 
Name Composition 
20x PBS 163.6 g NaCl 
 3.7 g KCl 
 28.8 g Na2HPO4 * 2 H2O 
 4.05 g KH2PO4 
  pH to 7.5 with HCl 
  ad 1000 ml dH2O 
  
Stir for 5 h and incubate overnight at room 
temperature (RT), autoclave for 15 min at 121 °C 
 
 
Table 16: 1x PBS (pH 7.5) 
Name Composition 
1x PBS 50 ml 20x PBS 
 950 ml DEPC-treated water 
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Table 17: 20% PFA (pH 7.5) 
Name Composition 
20% PFA 50 ml 20x PBS 
 700 ml DEPC-treated water 
 200 g PFA 
  Heat for 1 h at 65 °C, pH to 7.5 using NaOH 
  ad 1000 ml DEPC-treated water 
 
 
Table 18: 4% PFA 
Name Composition 
4% PFA 160 ml 1x PBS 
 80 µl 100% DEPC 
  
Stir for 5 h and incubate overnight at room 
temperature (RT), autoclave for 15 min at 121 °C 
  ad 160 ml DEPC-treated water 
 40 ml 20% PFA 
  Heat (~65 °C) till everything is dissolved 
 
 
Table 19: 0.4% PFA 
Name Composition 
0.4% PFA 196 ml 1x PBS 
 98 µl 100% DEPC 
  
Stir for 5 h and incubate overnight at room 
temperature (RT), autoclave for 15 min at 121 °C 
  ad 196 ml DEPC-treated water 
 4 ml 20% PFA 
  Heat (~65 °C) till everything is dissolved 
 
 
Table 20: 1 M Tris (pH 8.0) 
Name Composition 
1 M Tris pH 8.0 60.57 g Tris 
  pH to 8.0 with HCl 
  ad 500 ml DEPC-treated water 
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Table 21: 0.5 M EDTA (pH 8.0) 
Name Composition 
0.5 M EDTA (pH 8.0) 93.05 g Na2EDTA * 2 H2O 
  pH to 8.0 with NaOH 
  ad 500 ml DEPC-treated dH2O 
 250 µl 100% DEPC 
  
Stir for 5 h and incubate overnight at room 
temperature (RT), autoclave for 15 min at 121 °C 
 
 
Table 22: Proteinase K stock solution (10 mg/ml) 
Name Composition 
Proteinase K stock 100 mg Proteinase K 
 5 ml 1 M Tris (pH 8.0) 
 30 µl 1 M CaCl2 
 5 ml 100% Glycerol (sterile) 
  Aliquot and store at -20 °C 
 
 
Table 23: Proteinase K working solution 
Name Composition 
Proteinase K buffer 10 ml 1 M Tris (pH 8.0) 
 2.5 ml 0.5 M EDTA (pH 8.0) 
 187.5 ml DEPC-treated water 
 600 µl 
Proteinase K stock solution (10 mg/ml); added 
just before use 
 
 
Table 24: Acetylation buffer 
Name Composition 
Acetylation buffer 3.72 g Triethanolamine 
 200 ml DEPC-treated water 
 500 µl or 1000 µl Acetic anhydride – added just before use 
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Table 25: 10x salts buffer (pH 8.0) 
Name Composition 
10x Salts 11.40 g NaCl 
 1.404 g Tris HCl 
 0.134 g Tris 
 0.78 g NaH2PO4 * 2 H20 
 0.71 g Na2HPO4 * 2 H20 
 10 ml 0.5 M EDTA (pH 8.0) 
  ad 100 ml DEPC-treated water 
 
 
Table 26: Yeast tRNA solution 
Name Composition 
Yeast tRNA 500 mg  tRNA from baker’s yeast 
  ad 50 ml DEPC-treated water 
  Make 1 ml aliquots and freeze (-20 °C) 
 
 
Table 27: 50x Denhardt’s solution 
Name Composition 
50x Denhardt’s 1 g BSA 
 1 g Ficoll 400 
 1 g PVP 
  ad 100 ml DEPC-treated water 
 
 
Table 28: Hybridization buffer (pH 8.0) 
Name Composition 
Hybridization buffer 100 µl 10x Salts solution 
 500 µl Formamide (50%) 
 200 µl Dextran sulfate (10%) 
 100 µl Yeast tRNA 
 20 µl 50x Denhardt’s solution 
 80 µl DEPC-treated water 
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Table 29: 5x maleic acid buffer (5x MAB) (pH 7.5) 
Name Composition 
5x MAB 21.91 g NaCl 
 29.02 g Maleic acid (100%) 
 18 g NaOH 
 450 ml dH20 
  pH to 7.5 with HCl 
  ad 500 ml dH2O and filtrate 
 
 
Table 30: 1x MAB containing Tween 20 (MABT) 
Name Composition 
1x MABT 2 ml 5x MAB 
 8 ml dH2O 
 50 µl 10% Tween-20 
 
 
Table 31: 20x saline-sodium citrate (SSC) (pH 7.0) 
Name Composition 
20x SSC 175.3 g NaCl 
 88.2 g Sodium citrate dihydrate 
  pH to 7.0 with HCl 
  ad 1000 ml dH2O and autoclave 
 
 
Table 32: Post-hybridization washing solution (Post-Hyb Solution) 
Name Composition 
Post-Hyb Solution 25 ml 20x SSC 
 250 ml Formamide (100%) 
 5 ml 10% Tween-20 
 220 ml dH2O 
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Table 33: 1 M Tris (pH 7.5, 8.0 or 9.5) 
Name Composition 
1 M Tris (pH 7.5, 8.0 or 9.5) 121.14 g Tris 
  pH to 7.5 with HCl (for 10x RNase wash buffer) 
  pH to 8.0 with HCl (for RNase A stock solution) 
  pH to 9.5 with HCl (for NTMT buffer)  
  ad 1000 ml dH2O, respectively 
 
 
Table 34: 1 M MgCl2 
Name Composition 
1 M MgCl2 101.5 g MgCl2 * 6 H2O 
  ad 500 ml dH2O 
 
 
Table 35: 5 M NaCl 
Name Composition 
5 M NaCl 292.2 g NaCl 
  ad 1000 ml dH2O and autoclave 
 
 
Table 36: Preparation of stock solution of RNase A 
Name Composition 
RNase A Stock Solution 100 mg RNase A 
  Dissolve in 9 ml 0.01 M sodium acetat (pH 5.2) 
  Heat to 100 °C for 15 min 
  Cool to RT and add 1 ml 1 M Tris (pH 8.0) 
  Aliquot in 400 µl in aliquots and freeze at -20 °C 
 
 
Table 37: RNA wash buffer (10x) 
Name Composition 
RNA Wash Buffer (10x) * 400 ml 5 M NaCl 
 50 ml 1 M Tris (pH 7.5) 
 50 ml 0.5 M EDTA (pH 8.0) 
*diluted 1:10 with DEPC-treated water for 1x RNA Wash Buffer 
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Table 38: 10x Blocking reagent  
Name Composition 
Blocking Reagent 10 g Roche Blocking Reagent 
 100 ml 1x maleic acid buffer (MAB) 
  
Heat to dissolve, autoclave, aliquot (5-
10 ml) and freeze at -20 °C 
 
 
Table 39: Alkaline phosphatase buffer (NaCl, Tris, MgCl2, Tween-20, NTMT) (pH 9.5) 
Name Composition 
NTMT 4 ml 5 M NaCl 
 10 ml 1 M MgCl2 
 20 ml 1 M Tris (pH 9.5) 
 2 ml 10% Tween-20 
 100 mg 
Levamisole (add only to second 
wash and color reaction) 
(prepare freshly on day of use) 
 
 
Table 40: Staining solution 
Name Composition 
Staining Solution 4.5 µl NBT Color Substrate 
 2.5 µl BCIP Color Substrate 
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4.6 Kits 
 
Table 41: Kits used in the present study 
Name Source 
1,25-Dihydroxy Vitamin D enzyme immunoassay 
(EIA) 
Immunodiagnosticsystems, Boldon, United 
Kingdom 
2x Absolute qPCR SYBR Green Mix 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
GeneChip WT Terminal Labeling Kit Applied Biosystems, Foster City, USA 
GenElute Mammalian Total RNA Miniprep Kit Sigma-Aldrich, St. Louis, USA 
Mouse Direkt PCR Kit Biotool, South Loop West, USA 
Mouse PTH 1-84 ELISA Kit Immunotopics, San Clemente, USA 
Mouse/Rat IGF-I Quantikine ELISA Kit R&D Systems, Minneapolis, USA 
QIAshredder Qiagen, Hilden, Germany 
Q-Plex™ Mouse Cytokine Inflammation Kit Quansys Biosciences, Logan, USA 
RevertAid H Minus First Strand cDNA Synthesis Kit 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Thyroxine (T4) (Mouse/Rat) ELISA Kit BioVision, Milpitas, USA 
Zymoclean Gel DNA Recovery Kit Zymo Research, Irvine, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   4 Materials 
  
35 
4.7 Consumables 
 
Table 42: List of consumables used in the study 
Consumables Source 
15 ml and 50 ml falcons Sarstedt, Nümbrecht, Germany 
Biosphere tips with filters (10 µl, 100 µl, 200 µl 
and 1000 µl) 
Sarstedt, Nümbrecht, Germany 
Cell scrapers 25 cm Sarstedt, Nümbrecht, Germany 
Cover slips (24 x 60 mm) 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
GeneChip Mouse Gene 1.0 ST Array  Affymetrix, Santa Clara, USA 
Hypodermic needle, Gauge 14 Braun, Melsungen, Germany 
LightCycler 480 Multiwell Plate 96 Roche, Penzberg, Germany 
LightCycler 480 Sealing Foil Roche, Penzberg, Germany 
Multi Channel Pipettes 200 µl PeqLab, Crableck Lane, United Kingdom 
Multiply-µStrip Pro 8-strips Sarstedt, Nümbrecht, Germany 
Neubauer chamber 
Paul Marienfeld GmbH, Lauda-Königshofen, 
Germany 
Omnifix U-40 syringes Braun, Melsungen, Germany 
Pasteur pipettes Roth, Karlsruhe, Germany 
Plastic pestles Sigma-Aldrich, St. Louis, USA 
Precision wipes Kimtech Science, Surrey, United Kingdom 
Ritter riplates (2 ml, 96 well) Ritter, Schwabmünchen, Deutschland 
Rotilabo disposable weighing tray Roth, Karlsruhe, Germany 
Serological pipettes (10 µl, 100 µl, 200 µl, 
1000 µl) 
PeqLab, Crableck Lane, United Kingdom 
Serological pipettes (2 ml, 5 ml, 10 ml, 25 ml) Sarstedt, Nümbrecht, Germany 
Super polyethylene vials, 20 ml Perkin Elmer, Waltham, USA 
Superfrost Plus slides 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
T175 flasks Greiner bio-one, Kremsmünster, Austria 
T25 flasks Sarstedt, Nümbrecht, Germany 
TC dishes Sarstedt, Nümbrecht, Germany 
Tips (10 µl, 100 µl, 200 µl, 1000 µl) Sarstedt, Nümbrecht, Germany 
Tubes (0.5 ml, 1.5 ml, 2.0 ml) Eppendorf, Hamburg, Germany 
Vasco Sensitive L (gloves) Braun, Melsungen, Germany 
Whatman filters (liquid Scintillation Grade GF/B) 
Whatman International Ltd, Maidstone, United 
Kingdom 
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4.8 Technical devices 
 
Table 43: Equipment used in the present study 
Device Source 
Analytical balance KERN ALT220 Kern & Sohn GmbH, Balingen, Germany 
Aperio slide scanner AT2 Leica Biosystems, Wetzlar, Germany 
Axiovert 40 CFL microscope Carl Zeiss AG, Oberkochen, Germany 
Balancer PCB Kern & Sohn GmbH, Balingen, Germany 
Biometra Professional Trio PCR cycler Biometra, Göttingen, Germany  
BioPhotometer Plus Eppendorf, Hamburg, Germany 
Brandel cell harvester 9600-X Brandel, Gaithersburg, USA 
CM 3050S Cryotom Leica Biosystems, Wetzlar, Germany 
Compact M DNA electrophoresis chamber Biometra, Göttingen, Germany 
Easypet 3 pipette Eppendorf, Hamburg, Germany 
Electrophoresis power supply PeqLab, Crableck Lane, United Kingdom 
GeneChip scanner 3000 Affymetrix, Santa Clara, USA 
HERA 240 CO2 cell culture incubator 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Heraeus Pico 17 (bench centrifuge) 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Heraeus T6060 drying chamber Heraeus, Hanau, Germany 
Infinity-3026 WL/26MX gel documentation 
system 
PeqLab, Crableck Lane, United Kingdom 
Liebherr MEDline (4°C) refrigerator Liebherr, Bulle, Switzerland 
LightCycler 480 II Roche, Penzberg, Germany 
MAXQ 6000 shaker 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Metabolic cages Acme Metal Products, Statesville, USA 
Mettler Toledo XS 205 Mettler-Toledo, Columbus, USA 
Micropipettes (10, 100, 200, 1000 µl) PeqLab, Crableck Lane, United Kingdom 
Microwave oven Severin, Sundern, Germany 
Multiplate reader FLUOstar Omega Labtech, Offenburg, Germany 
NanoDrop Spectrophotometer 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Olympus CX41 microscope Olympus, Tokyo, Japan 
Thermo Scientific Forma 900 freezer (-80°C) 
Thermo Fisher Scientific Inc., Schwerte, 
Germany 
Thermomixer Eppendorf, Hamburg, Germany 
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Vortex IKA MS3 basic Ika, Staufen, Germany 
Wallac 1414 Win Spectral Liquid Scintillation 
Counter 
Perkin Elmer, Waltham, USA 
WTW series pH 720 pH meter inoLab, Weilheim, Germany 
ZEISS LSM 880 Confocal Laser Scanning 
Microscope 
Carl Zeiss AG, Oberkochen, Germany 
Ziegra ice machine ZIEGRA Eismaschinen, Isernhage, Deutschland 
 
 
4.9 Software 
 
Table 44: Software used in this study 
Software Source 
CellSens 1.7.1 cell Imaging software Olympus, Tokyo, Japan 
ELISA Analyse www.elisaanalysis.com 
Environment R (version 3.1.2) www.R-project.org 
Expression Console (version 1.4.0) Affymetrix, Santa Clara, USA 
GraphPad Prism 7 GraphPad Software, La Jolla, USA 
ImageScope Leica Biosystems, Wetzlar, Germany 
Ingenuity pathway analysis (IPA) Qiagen, Hilden, Germany 
IrfanView Irfan Skiljan, Wien, Austria 
LightCycler 480 Software Roche, Penzberg, Germany 
Microsoft 2007 Professional Microsoft, Redmond, USA 
Microsoft Office 2010 Microsoft, Redmond, USA 
Universal ProbeLibrary System Assay Design Roche, Penzberg, Germany 
ZEN2.3 software Carl Zeiss AG, Oberkochen, Germany 
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5 Methods 
 
5.1 Mice strains used in the present study 
 
For a tissue-specific introduction of a loss-of-function mutation in Trpm7, we used the LoxP/Cre 
approach and a recently generated mouse strain with a conditional Trpm7 fl allele [59]. Cre 
recombinase recognizes 34 bp DNA sequence (LoxP sites) and enables to delete a genomic 
sequence located between two  oxP sites (often referred to as a ‘floxed’ sequence). Cre-induced 
deletion of exon 17 in Trpm7 fl allele (Table 45) results in a frame-shift mutation (Trpm7 Δ17 allele) 
i.e. in null mutation of Trpm7 [59]. For tissue-specific inactivation of Trpm7, transgenic mouse 
strains expressing Cre in a tissue-specific mode were used (Table 45). 
 
 
Table 45: Mutant mouse lines used in this study 
Mutant 
allele 
Description 
Genetic 
background 
Source 
Trpm7 fl 
Conditional (floxed) 
mutation in Trpm7  
129S6/SvEvTac 
David Clapham’s laboratory  Harvard 
Medical School, Boston, USA [59] 
Trpm7 ki 
Point mutation K1646R 
in Trpm7 
129S6/SvEvTac 
Masayuki Matsushita’s laboratory  
Mitsubishi Kagaku Institute of Life 
Science, Machida, Tokyo, Japan [65] 
Villin1-Cre Villin1-Cre transgene C57BL/6J 
Jackson Laboratory, Bar Harbor, 
Maine, USA (stock #004586) [134] 
Ksp1.3-Cre Ksp1.3-Cre transgene C57BL/6J 
Jackson Laboratory, Bar Harbor, 
Maine, USA (stock #012237) [135] 
 
 
For inactivation of Trpm7 in the epithelial cells of the whole intestine, Villin1-Cre [134] and for the 
ablation of Trpm7 in renal epithelial cells of collecting duct, distal convoluted tubule (DCT) and thick 
ascending limb of Henle, Ksp1.3-Cre [135] was used (Table 45). To investigate a role of TRPM7 
kinase  we used a mouse line with a ‘kinase-dead’ knock-in point mutation K1646R (Trpm7 ki allele 
(Table 45)) resulting in a complete block of TRPM7 kinase catalytic activity in the whole body [65]. 
 
 
5.2 Breeding of gene-modified mice 
 
To maintain the Trpm7 fl/fl strain, we bred females with males homozygous for Trpm7 fl. F1 Trpm7 fl/fl 
females (8-10 weeks old) were used to generate animals carrying organ-specific mutations in 
Trpm7 (Table 46). To generate mice lacking TRPM7 in the intestinal enterocytes, we crossed 
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Trpm7 fl/fl females with Villin1-Cre-positive Trpm7 fl/wt males. F1 Trpm7 fl/fl; Villin1-Cre (Intestine KO) 
and Trpm7 fl/fl (Control) male littermates were examined. To produce mice lacking TRPM7 in the 
renal epithelial cells, we crossed Trpm7 fl/fl females with Ksp1.3-Cre-positive Trpm7 fl/fl males. F1 
Trpm7 fl/fl; Ksp1.3-Cre (Kidney KO) and Trpm7 fl/fl (Control) male littermates were examined. 
To produce mice with a global TRPM7 ‘kinase-dead’ mutation  males and females heterozygous for 
the Trpm7 ki allele were crossed. F1 Trpm7 ki/ki (kinase-dead) and Trpm7 wt/wt (Control) littermates 
were used for experiments. 
 
 
Table 46: Generation of mice with global and tissue-restricted mutations of Trpm7 
Targeted tissue Breeding strategy Expected F1 outcome a 
Intestine 
♂Trpm7 fl/wt; Villin1-Cre x 
♀Trpm7 fl/fl 
25% Trpm7 fl/fl; Villin1-Cre b  
25% Trpm7 fl/fl 
25% Trpm7 fl/wt; Villin1-Cre 
25% Trpm7 fl/wt 
Kidney 
♂Trpm7 fl/fl; Ksp1.3-Cre x 
♀Trpm7 fl/fl 
50% Trpm7 fl/fl; Ksp1.3-Cre b 
50% Trpm7 fl/fl 
Global 
♂Trpm7 ki/wt x 
♀Trpm7 ki/wt 
25% Trpm7 ki/ki 
50% Trpm7 ki/wt 
25% Trpm7 wt/wt 
a Genotypes were determined using genomic DNA extracted from tail fragments.  
b Mice were assumed to be homozygous for Trpm7 Δ17 allele in the cells expressing Cre. 
 
 
Phenotypic assessments of Trpm7 ki/ki and Trpm7 fl/fl; Ksp1.3-Cre mice were performed with 8-
weeks old male littermates. Because of a high postnatal mortality rate, Trpm7 fl/fl; Villin1-Cre mice 
(both males and females) were investigated at 1, 3 or 5 days after birth. 
 
 
5.3 Genotyping of mice 
 
The genomic DNA was extracted from tail segments using Mouse Direct PCR Kit according to the 
manufacturer’s protocol. DNA extracts were analyzed by allele-specific PCRs using the Biometra 
Professional Trio PCR Cycler. 0.5 µl DNA extract was added to the master mix as outlined in Table 
47. PCR primers and expected PCR amplicons are described in Table 48. Settings of PCRs are 
shown in Table 49-Table 52. 
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Table 47: Composition of the PCR master mix 
Reagent Volume 
2 x M-PCR OPTI™ Mix* 10 µl 
Forward Primer 0.1 µl (100 pmol/µl) 
Reverse Primer 0.1 µl (100 pmol/µl) 
dH20 9.3 µl 
* from Mouse Direkt PCR Kit 
 
 
Table 48: Primer pairs for specific alleles and length of the amplicon 
Allele Primer Amplicon 
Trpm7 wt 
Forward primer: mTrpm7 wt for 
Reverse primer: mTrpm7 wt rev 
336 bp 
Trpm7 fl 
Forward primer: mTrpm7 wt for 
Reverse primer: mTrpm7 wt rev 
446 bp 
Villin1-Cre 
Forward primer: mVillin1-Cre for 
Reverse primer: mVillin1-Cre rev 
195 bp 
Ksp1.3-Cre 
Forward primer: mKsp1.3-Cre for 
Reverse primer: mKsp1.3-Cre rev 
420 bp 
Trpm7 ki 
Forward primer: mTrpm7 ki for 
Reverse primer: mTrpm7 ki rev 
205 bp 
 
 
Table 49: PCR settings for Trpm7 
wt
 / Trpm7 
fl
 
Step Temperature Time Number of cycles 
Initialization step 95 °C 05:00 min 1 
Denaturation 
Annealing 
Elongation 
95 °C 
58 °C (-1 °C per cycle) 
72 °C 
00:30 min 
00:30 min 
01:00 min 
10 
Denaturation 
Annealing 
Elongation 
95 °C 
48 °C 
72 °C 
00:30 min 
00:30 min 
01:00 min 
35 
Final extension 72 °C 05:00 min 1 
Cooling 16 °C ∞ 1 
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Table 50: PCR conditions for Villin1-Cre  
Step Temperature Time Number of cycles 
Initialization step 95 °C 02:00 min 1 
Denaturation 
Annealing 
Elongation 
95 °C 
65 °C (-1.5 °C per cycle) 
72 °C 
00:20 min 
00:15 min 
00:10 min 
10 
Denaturation 
Annealing 
Elongation 
95 °C 
50 °C 
72 °C 
00:15 min 
00:15 min 
00:10 min 
30 
Final extension  72 °C 02:00 min 1 
Cooling 16 °C ∞ 1 
 
 
Table 51: PCR settings for Ksp1.3-Cre 
Step Temperature Time Number of cycles 
Initialization step 95 °C 02:00 min 1 
Denaturation 
Annealing 
Elongation 
95 °C 
65 °C (-0.5 °C per cycle) 
72 °C 
00:20 min 
00:15 min 
00:10 min 
10 
Denaturation 
Annealing 
Elongation 
95 °C 
60 °C 
72 °C 
00:15 min 
00:15 min 
00:20 min 
30 
Final extension 72 °C 02:00 min 1 
Cooling 16 °C ∞ 1 
 
 
Table 52: PCR conditions for Trpm7 
ki
 
Step Temperature Time Number of cycles 
Initialization step 95 °C 05:00 min 1 
Denaturation 
Annealing 
Elongation 
95 °C 
65 °C (-1 °C per cycle) 
72 °C 
00:30 min 
00:30 min 
01:00 min 
10 
Denaturation 
Annealing 
Elongation 
95 °C 
55 °C 
72 °C 
00:30 min 
00:30 min 
01:00 min 
40 
Final extension 72 °C 05:00 min 1 
Cooling 16 °C ∞ 1 
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For genotyping of Trpm7 ki and Trpm7 wt alleles, PCR products were further exposed to Tru1I 
endonuclease for 16 h at 65 °C (Table 53). Tru1I digests the PCR product from Trpm7 wt allele 
producing 120 and 85 bp fragments, whereas Trpm7 ki amplicon (205 bp) remains unchanged.  
 
 
Table 53: Conditions used for Tru1I digestion of Trpm7 
ki
 and Trpm7 
wt
 PCR amplicons 
Reactant Volume 
PCR product 20 µl 
Buffer R 2.5 µl 
dH2O 2.0 µl 
Tru1I endonuclease 0.5 µl 
 
 
PCR products were analyzed using agarose gel electrophoresis. Gels were prepared using 
agarose (1–3% m/v) and 15 µl Roti-GelStain dissolved in hot 1x TAE buffer. Either O’GeneRuler 
Low Range DNA Ladder or GeneRuler 100 bp DNA Ladder was used to estimate the size of PCR 
products. Gels were run for 25 min at 150 V and imaged using the Infinity-3026 WL/26MX gel 
documentation system. The obtained images were analyzed using IrfanView software.  
 
 
5.4 Housing conditions of mice 
 
5.4.1 Normal housing conditions 
 
All experiments involving animals were in accordance with the EU Animal Welfare Act and were 
approved by the local councils on animal care (permit Nr. 55.2-1-54-2532-180-2016 and permit Nr. 
55.2-1-54-2532-134-13 from the Government of Upper Bavaria). Mice were bred in the animal 
facility of the Walther Straub Institute of Pharmacology and Toxicology. Mice were kept in 
individually ventilated polycarbonate cages. Cages were changed weekly and were on a 12 h 
light/dark cycle with artificial lighting. Temperature and relative humidity were 22+/-1 °C and 
50+/-5 %, respectively. For enrichment, animals received wood wool and bedding material. 
Breeding animals were maintained on multigrain chow Ssniff M-Z (Table 54) and regular drinking 
water from tap containing 20.4 mg/l Mg2+, 79.6 mg/l Ca2+ and <0.2 mg/l Zn2+ (ad libitum). Litters 
were weaned at three weeks of age. Littermates were housed in cages as described above but that 
‘maintenance’ chow Ssniff R/M-H was used (Table 54). All chows were purchased from Ssniff 
GmbH (Soest, Germany). 
 
 
   5 Methods 
  
43 
Table 54: Chows used for housing of mice 
Chow Composition 
Total content of divalent cations 
Mg2+ (%) Ca2+ (%) Zn2+ (%) 
Regular for breeding  Ssniff M-Z (Zucht) 0.22 1.00 0.089 
Regular for maintenance Ssniff R/M-H (Haltung) 0.22 1.00 0.089 
High Mg2+ chow Ssniff M-Z + 0.53% Mg2+ * 0.75 1.00 0.089 
High Ca2+ chow 
Ssniff M-Z + 1.00% Ca2+; 
+ 0.55% P ** 
0.22 2.00 0.089 
High Ca2+/Mg2+ chow 
Ssniff M-Z + 0.53% Mg2+ *; 
+ 1.00% Ca2+; + 0.55% P ** 
0.75 2.00 0.089 
* Content of Mg2+ was increased using MgO; 
** Content of Ca2+ was increased using CaCO3 and Ca(H2PO4)2 to avoid P deficiency. 
 
 
5.4.2 Dietary Mg2+, Ca2+ and Zn2+ fortifications of mice 
 
For supplementation experiments with Trpm7 fl/fl; Villin1-Cre mice, breeding couples and their 
weaned offspring were maintained ad libitum on different dietary regimes as outlined in Table 55. 
The control diet was based on a regular Ssniff M-Z chow and deionized drinking water (dH2O). For 
Mg2+ and Ca2+ supplementation, a regular Ssniff M-Z contained additional Mg2+ and Ca2+ salts as 
explained in Table 54. For Zn2+ supplementation, animals were fed by the standard Ssniff M-Z chow 
and dH2O containing 0.1% Zn
2+. Finally  a ‘triple diet’ contained high levels of all three cations Mg2+, 
Ca2+ and Zn2+ (Table 55). For determination of mortality rates, the breeding pairs and pups were 
examined twice per day. Dead pups and animals, which were expected to die within the next 24 h, 
were euthanized for ethical reasons, collected and genotyped. Kaplan-Meier distributions and 
statistical analysis were computed by the log-rank test using GraphPad Prism. 
 
 
Table 55: Dietary treatments used for survival experiments 
Diet Chow Drinking water 
Control diet Ssniff M-Z dH20 
High Mg diet High Mg2+ chow dH20 
High Ca diet High Ca2+ chow dH20 
High Zn diet Ssniff M-Z dH20 + 0.1% Zn
2+ 
Triple diet 
(high Mg2+, Ca2+ and Zn2+) 
High Ca2+/Mg2+ chow dH20 + 0.1% Zn
2+ 
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5.5 Collection of murine specimen 
 
5.5.1 Collection of serum and bones 
 
8 weeks old mutant and control mice were weighed (Balance PCB), anesthetized by isoflurane and 
euthanatized by cervical dislocation. Blood samples were collected by a cardiac puncture technique 
(using Omnifix U-40 syringe and hypodermic needle). In experiments with 1, 3 or 5 days old Trpm7 
fl/fl; Villin1-Cre and Trpm7 fl/fl pups, animals were euthanatized by beheading and released blood 
was collected by a 100 µl pipette. To isolate serum, the blood samples were incubated 20-40 min at 
RT and clots were removed by centrifugation (Heraeus Pico 17 centrifuge, 30 min, 3.500 rpm, RT). 
The clear serum fraction was removed and stored at -80 °C. Right tibias were dissected, cleaned 
from muscle tissue, dried overnight at 70 °C in a Heraeus drying chamber and kept at RT. 
 
 
5.5.2 Collection of urine 
 
To determine the urinary excretion rates of divalent cations, individual Trpm7 fl/fl; Ksp1.3 and 
Trpm7 fl/fl mice were maintained for 20 h in individual metabolic cages. Animals were supplied ad 
libitum with a regular chow and regular drinking water. The produced urine was collected and 
stored at -80 °C. 
 
 
5.5.3 Isolation of villi for RNA isolation and microscopically examination 
 
The whole intestine of 5 days old Trpm7 fl/fl; Villin1-Cre and Trpm7 fl/fl mice was removed and cut 
longitudinally. The tissues were flushed 1 x with ice-cold PBS and 3 x with ice-cold PBS containing 
1 mM DTT. Next, the tissues were incubated in 4 ml Villi isolation buffer A for 15 min on ice. 
Intestine was transferred to 1.5 ml buffer B and rotated (250 rpm) for 15 min at 10 °C (MAXQ 6000 
shaker). After that, the samples were vortexed (Vortexer IKA MS3 basic) 5 x for 10 s (3.000 rpm). 
The intestine was removed and supernatants were centrifuged for 30 s at 13.000 g and 4 °C 
(Heraeus Pico 17). The pellets were flash frozen at -80 °C and used later for RNA isolation. The 
isolated villi were examined using an Olympus CX41 microscope and Cell Imaging software. 
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5.5.4 Isolation of villi from the small intestine for microarray analysis 
 
The small intestine was removed from 5 days old Trpm7 fl/fl; Villin1-Cre and Trpm7 fl/fl mice and cut 
longitudinally. After washing with 1 ml ice-cold PBS, the tissue was transferred in 1 ml RNAlater 
RNA Stabilization Reagent (RT). The samples were vortexed 20 x (3.000 rpm) for 10 s at RT. After 
removal of the remaining gut, the obtained villi fraction was examined visually using the Axiovert 40 
CFL microscope. The villi were stored at 4 °C. Prior RNA isolation (5.7.1), the villi were collected by 
centrifugation for 1 min at 17.000 g (Heraeus Pico 17) at RT. 
 
 
5.5.5 Isolation of kidney and duodenum for RNA isolation 
 
To isolate RNA from the kidneys of Trpm7 fl/fl; Ksp1.3-Cre and Trpm7 fl/fl animals, the left kidney was 
cut transversally. The whole upper part was quickly placed in 500 µl RNAlater RNA Stabilization 
Reagent. To prepare RNA from the duodenum, the proximal part (1 cm) of the intestine was 
removed and placed in 500 µl RNAlater RNA Stabilization Reagent (RT). The samples were 
incubated for 24 h at 4 °C and afterwards used for RNA isolation (5.7.1). For long-time storage, the 
tissue samples were kept frozen at -20 °C. 
 
 
5.5.6 Isolation of mouse tissues for histological analysis  
 
For the histological analysis of the intestine of P1 Trpm7 fl/fl; Villin1-Cre and Trpm7 fl/fl mice, 1 cm 
segments of duodenum, jejunum, ileum and colon were dissected. For examination of lymphoid 
organs, the whole thymus and spleen were dissected and balanced. The tissues were incubated in 
4% PFA in PBS for 24 h at 4 °C. Afterwards, the tissues were stored in 0.4% PFA in PBS at 4 °C. 
 
 
5.5.7 Preparation of kidneys for in situ hybridization (ISH) 
 
Kidneys of Trpm7 fl/fl; Ksp1.3-Cre and Trpm7 fl/fl animals were removed and incubated in DEPC-
treated 4% PFA in PBS and stored for 24 h at 4 °C. Afterwards, the tissues were incubated in 
DEPC-treated 0.4% PFA in PBS at 4 °C. 
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5.6 Cell culture 
 
5.6.1 Culturing of HAP1 cells 
 
Wildtype (parental) HAP1 clone (C631) and TRPM7-deficient clones (10940–01 and 10940–04) 
were reported previously [44] (Horizon Genomics  Vienna  Austria). Cells were cultured in Iscove’s 
Modified Dulbecco’s Medium (IMDM) supplemented with 10% FBS, 100 µg/ml streptomycin, 100 
U/ml penicillin and 10 mM MgCl2. Cells were cultivated in HERA 240 incubator at 37 °C and 5% 
CO2. For maintaining of the lines, cells were grown until 80-90% confluency in T25 flasks, washed 
1 x with PBS and treated with 3 ml trypsin-EDTA solution for 3 min at 37 °C. Trypsin treatment was 
stopped by adding 9 ml of IMDM. Cells were centrifuged for 2 min at RT and 1.200 rpm (Heraeus 
Pico 17). The cell pellets were resuspended (1:10 or 1:20) in IMDM in a new T25 flask. 
 
 
5.6.2 Preparation of HAP1 cells for ICP-MS analysis 
 
Wildtype HAP1 clone C631 and TRPM7-deficient clones 10940–01 and 10940–04 were grown in 
T175 cm2 flasks as described above (section 5.6.1). At ~50% confluence, the medium was re-
placed by fresh IMDM medium without additional 10 mM MgCl2. In some experiments, 50 µM 
ZnSO4 was added to IMDM. Next, cells were cultured for additional 24 h, washed 1 x with PBS 
(RT), trypsinized and collected in 50 ml falcons. After centrifugation (3 min, 1.200 rpm, RT) and 
removal of the supernatant, the obtained cell pellets were resuspended in 1 ml PBS and passed to 
fresh 1.5 ml Eppendorf tubes. The cell suspension was centrifuged (3 min, 3.500 rpm, RT) and 
supernatants were removed. The cell pellets were dried overnight at 70 °C in a Heraeus drying 
chamber. The dried cell pellets were analyzed using ICP-MS at ALS Scandinavia (Sweden), as 
described in 5.8. 
 
 
5.6.3 65Zn uptake assay 
 
Wildtype HAP1 cells (clone C631) and a TRPM7-deficient cell line (clone 10940–04) were grown to 
~ 90% confluency in T175 flasks and washed 1 x with PBS (RT). Afterwards, 10 ml PBS were 
added and cells were disaggregated using a cell scraper. After centrifugation (1.200 g, 3 min, RT), 
the cell pellets were resuspended in 10 ml HBS (RT). Cells were counted using the Neubauer 
chamber and cell densities were adjusted to a similar level (~5*106 cells/ml) using HBS. 600 µl of 
the cell suspension (~3 x 106 cells, quadruplicates) were pipetted to a 96 well Ritter Riplate. HBS 
was used to estimate a blank value. Next, 300 µl HBS containing 6 mM 65ZnCl2 (2 mM final 
concentration) were added at 37 °C for different time intervals. Cells were harvested using 
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Whatman filter papers (for Liquid Scintillation Grade GF/B) and a Brandel cell harvester 9600-X. 
The filters were washed 4 x with 2 ml dH20. The filters were placed in the Super polyethylene vials 
containing 5 ml Rotiszint lysis/scinctilation solution. After 24 h, radioactivity was detected with the 
Wallac 1414 Win Spectral Liquid Scintillation Counter. The obtained datasets were fitted using a 
nonlinear (least-squares) regression analysis (GraphPad Prism 7.3) and one-phase exponential 
association equation: 
B = Bmax (1 - e 
-K t) 
with B - cellular content of 65Zn2+ (dpm / µg protein), t - time (min), Bmax - maximum 
65Zn2+ level at 
equilibrium (dmp / µg protein), K - a rate constant (min-1). Statistical analysis was performed using 
the extra sum-of-squares F test (GraphPad Prism 7.3) with a threshold of P≤0.05. 
 
 
5.7 Biochemical and molecular biology methods 
 
5.7.1 RNA isolation and first strand cDNA synthesis 
 
For RNA isolation, the GenElute Mammalian Total RNA Miniprep Kit was used. Tissue samples 
were removed from RNAlater RNA Stabilization Reagent and placed in a 1.5 ml plastic tube 
containing 500 µl lysis solution and 1% β-mercaptoethanol (both from GenElute Mammalian Total 
RNA Miniprep Kit). Tissues were homogenized by QIAshredder and RNA isolation was performed 
according to the manufacturer’s protocol. The obtained RNA samples were diluted in 50 µl 
nuclease-free water. The concentration of RNA was determined spectroscopically at 260 nm with 
BioPhotometer plus. For the synthesis of cDNA, the RevertAid H Minus First Strand cDNA 
Synthesis Kit was used according to the manufacturer’s protocol as outlined in Table 56 and Table 
57. The produced cDNA samples were stored at -20 °C. 
 
 
Table 56: Reaction mixture for cDNA synthesis 
Reagents  Volume 
mRNA x µL (1 µg) 
Random Hexamer Primer (100 µM) 1 µl 
Nuclease-free water x µl, to make up 12 µl 
5x Reaction Buffer 4 µl 
RiboLock RNase Inhibitor (20 u/µl) 1 µl 
10 mM dNTP Mix 2 µl 
RevertAid H Minus M-MuLV Reverse Transcriptase 1 µl 
 
 
   5 Methods 
  
48 
Table 57: Reaction conditions for cDNA synthesis 
Temperature Time 
25 °C 5 min 
42 °C 60 min 
70 °C 5 min 
 
 
5.7.2 Quantitative real-time polymerase chain reaction (qRT-PCR) 
 
qRT-PCR was performed using a master mix (Table 58) pipetted in the LightCycler 480 Multiwell 
Plate (20 µl per well). Then, 5 µl/well diluted cDNA (1:5) were added. All pipetting steps were 
performed on ice. The plates were sealed using the LightCycler 480 sealing foil. Expression levels 
of target genes were normalized to expression levels of reference genes. For intestine samples, 
hypoxanthin-phosphoribosyl-transferase (Hprt) was used; for kidney samples, 14-3-3 protein 
zeta/delta (Ywhaz) was employed. PCR primers (Table 4) were designed using the Roche Assay 
Design Center software. qRT-PCR was performed using LightCycler 480 II and conditions shown in 
Table 59. Analysis of the data was performed with the LightCycler 480 software. The relative mRNA 
expression levels were calculated using the 2-ΔΔCt approach. Statistical analysis was performed 
using an unpaired Student’s t-test with Excel (Microsoft Office 2010). 
 
 
Table 58: qRT-PCR master mix 
Reagents Volume 
2x Absolute qPCR SYBR Green Mix 12.5 µl 
Primer forward (100 µM) 0.1 µl 
Primer reverse (100 µM) 0.1 µl 
Nuclease-free water 7.3 µl 
 
 
Table 59: qRT-PCR settings 
Step Temperature Time Cycles 
Initialization step 95 °C 15:00 min 1 
Denaturation 
Annealing 
Elongation 
95 °C 
60 °C 
72 °C 
00:15 min 
00:15 min 
00:30 min 
40 
Melting curve analysis 
95 °C 
60 °C 
00:10 min 
01:00 min 
1 
Cooling 40 °C ∞ 1 
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5.7.3 In situ hybridization (ISH) 
 
To examine the efficiency of the Trpm7 gene deletion via Ksp1.3-Cre recombinase in 
Trpm7 fl/fl; Ksp1.3-Cre mice in the kidney, we used in situ hybridization (ISH). ISH was performed in 
collaboration with the laboratory of Dr. David Simmons, Brisbane, Australia. cDNA templates for the 
generation of cRNA Trpm7 probes were produced using PCR as outlined in Table 60 and Table 61. 
The primers contained either T7 or T3 promoter RNA polymerase sites. 
 
 
Table 60: Composition of PCR mix to produce ISH probes 
Reagent Concentration Volume 
Taq DNA polymerase 5 U/ml 0.1 µl 
Standard Taq buffer 1x 2 µl 
dNTPs 10mM 0.4 µl 
cDNA 1x 2 µl 
Primer mix (Trpm7 ex17 for/rev) 10mM 2 µl 
TMAC 1x 2 µl 
RNase free water  1x 11.5 µl 
 
 
Table 61: PCR settings used for generation of ISH probes 
Step Temperature Time Cycles 
Initialization step 94 °C 03:00 min 1 
Denaturation 
Annealing 
Elongation 
94 °C 
62 °C 
72 °C 
00:30 min 
00:30 min 
00:45 min 
35 
Final Extension 72 °C 05:00 min 1 
Cooling 4 °C ∞ 1 
 
 
The PCR products were separated using agarose gel electrophoresis. The corresponding PCR 
products were cut from the gel, purified using the Zymoclean Gel DNA Recovery Kit according to 
the manufacturer’s protocol and quantified by the NanoDrop spectrophotometer. To produce 
Digoxigenin (DIG)-labelled sense and antisense ISH probes, the purified PCR products were 
incubated either with T3 RNA or T7 RNA polymerase at 37 °C for 90 min as shown in Table 62. 
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Table 62: Components for production of sense and antisense RNA probes 
Reagent Volume 
Reagent x µl (100 ng) 
Purified PCR product 1 µl 
5x Transcription buffer 1 µl 
10x DIG RNA Labeling mix 2 µl 
RNA polymerase T3/T7 1 µl 
RNase free water ad 20 µl 
 
 
The synthesis was stopped by addition of 1 µl 0.2 M EDTA, 1.25 µl 4 M LiCl and 37.5 µl EtOH 
(100%). The reaction mixtures were incubated overnight at -20 °C. ISH probes were precipitated by 
centrifugation at 13.000 rpm for 20 min at 4 °C. The pellets were washed with 500 µl EtOH (70%) 
and centrifuged for 10 min at 13.000 rpm at 4 °C. Supernatants were removed and the pellets were 
resuspended in 11 µl RNase free water. The generated ISH probes were diluted 1:10 in 
hybridization buffer and stored at -80 °C. 
For paraffin embedding of fixed kidneys isolated from Trpm7 fl/fl; Ksp1.3-Cre and Trpm7 fl/fl mice 
(5.5.7), the tissues were washed 3 x in PBS, incubated for 1 h in 70% EtOH and 1 h in 100% EtOH. 
Afterwards, the tissues were incubated in 100% xylene for 1 h and in 3 paraffin baths (2x 30 min 
and 1x 1 h). The tissues were embedded in paraffin wax blocks. The blocks were used to produce 
7 µm sections (Cryotom CM 3050S) and transferred onto the Superfrost plus slides. Slides were 
dewaxed 2x in 100% xylene for 10 min. After rehydration with decreasing concentrations of EtOH 
(2x 100% for 10 min and 95%, 70%, 50% as well as 30% for 5 min) and following a 5 min wash in 
PBS, the slides were fixed in 4% PFA in PBS for 10 min and washed 2x in PBS for 5 min. The 
slides were placed into proteinase K buffer for 20 min and washed 1x with PBS, 1x in 4% PFA in 1x 
PBS and 1x in PBS for 5 min, respectively. 
The ISH probes were further diluted (1:2.000) in a hybridization buffer and heated at 70 °C for 
10 min. Next, the probes were added to the kidney sections (150-200 µl per section) and hybridized 
overnight in a sealed humidified box at 65 °C. The slides were washed 2x in pre-heated post-
hybridization wash solution at 65 °C for 30 min, followed by 2 washes in 1x MABT at RT for 30 min. 
Next, the slides were washed in 1x RNA wash buffer 3x at 37 °C (1st wash 10 min, 2nd wash 30 min, 
3rd wash 5 min), whereupon RNase A (400 µl RNase A Stock Solution per 200 ml) was added into 
the 2nd wash. After that, the slides were washed 5 min at RT in 1x MABT. For blocking, the slides 
were covered with 300 µl 1x MABT with 2% blocking reagent stock and 20% heat-inactivated goat 
serum for 1 h (blocking solution). Afterwards, anti-DIG-AP antibody was diluted in blocking solution 
(1:2.500). 300 µl of the solution were added on each slide, covered by a cover slip and incubated at 
4 °C overnight in a humidified chamber. 
All further steps were performed at RT. First, slides were washed 4x in 1x MABT for 15 min. 
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Afterwards, the slides were washed with NTMT and NTMT with added levamisole for 10 min, 
respectively. Slides were covered with cover slips after addition of 300 µl staining solution. The 
color reaction was developed for 3 days. When purple staining was detectable, the reaction was 
stopped with PBS wash. Slides were rinsed for 1 min with dH2O. Afterwards, the slides were 
immersed in Nuclear Fast Red (30 s) and rinsed again for 1–2 min in tap water. Next, slides were 
dehydrated through alcohol washes in increasing concentrations followed by xylene (30%, 50%, 
70%, 95%, 2x 100% EtOH for 1 min, respectively; 2x xylene for 2 min, respectively). Finally, slides 
were mounted in DPX mounting medium, covered by cover slips and air dried. Slides were imaged 
by the Aperio slide scanner and examined using the ImageScope software. 
 
 
5.7.4 Whole-genome profiling of the villi transcriptome  
 
Isolation of intestinal villi and RNA is described under 5.5.4 and 5.7.1, respectively. Whole genome 
profiling was conducted using the Affymetrix GeneChip Mouse Gene 1.0 ST Array at Source 
Bioscience (Berlin, Germany) as described previously [44]. Processing of the array data, including 
background correction, quality assessment and normalization was performed with the Affymetrix 
Expression Console (version 1.4.0). Differential expression analysis was performed with the 
DNASTAR ArrayStrar 11.0 software. P-values (Student’s t-test) were adjusted for multiple testing by 
the Benjamini-Hochberg method for controlling the false discovery rate (FDR). Analysis of the 
affected gene networks was performed by the Ingenuity pathway analysis (IPA) computer 
environment using a set of 455 transcripts with ≥ 2.0-fold change at P≤0.05. Microarray data were 
deposited in NCBI Gene Expression Omnibus (GEO) (GSE110613). 
 
 
5.7.5 Enzyme-linked immunosorbent assays (ELISA)  
 
For analysis of serum IGF-1, we used the Mouse/Rat IGF-1 Quantikine ELISA Kit. The content of 
thyroxine (T4) was determined by the Thyroxine (T4) (Mouse/Rat) ELISA Kit. Levels of parathyroid 
hormone (PTH) were measured using the Mouse PTH 1-84 ELISA Kit. Analysis of cytokines was 
performed by Quansys Biosciences using the Q-Plex™ Mouse Cytokine Inflammation Kit. For 
determination of 1,25-dihydroxy vitamin D we used the 1,25-Dihydroxy Vitamin D EIA. For the 
1,25-Dihydroxy Vitamin D assay, samples from 3-7 animals were combined since 100 µl was the 
minimum sample volume. Procedures were performed according to the manufacturer`s protocols. 
Color reactions were analyzed using the plate reader FLUOstar Omega. Data were analyzed using 
Excel 2010 (Microsoft 2007 Professional) and ELISA Analysis. 
 
 
   5 Methods 
  
52 
5.8 Inductively coupled plasma mass spectrometry (ICP-MS) 
 
The content of main elements in HAP1 cells, serum, bones and urine samples was determined by 
inductively coupled plasma mass spectrometry (ICP-MS). The measurements were performed at 
ALS Scandinavia (Sweden) as reported earlier [44, 66, 136, 137].  
 
 
5.9 Histological examination of the intestine 
 
The experiments were performed in collaboration with Dr. Camilla Recordati (Mouse and Animal 
Pathology Laboratory, Filarete Foundation, Milan, Italy). Tissues (5.5.6) were dehydrated through a 
series of ethanol washes and cleared in three changes of xylene. Afterwards, the samples were 
embedded in paraffin. Tissue sections (4 μm) were mounted on Superfrost Plus slides and dried at 
70 °C for 1 h. Tissue sections were dewaxed in xylene and rehydrated through a series of ethanol 
washes to dH2O. Slides were incubated in Mayer’s hematoxylin solution for 10 min at RT followed 
by incubation in 0.5% Eosin G solution for 10 min at RT. The color reaction was stopped by 
deionized water. Slides were dehydrated in ethanol, cleared in xylene and mounted in mounting 
medium. Slides were examined using the DM2500 light microscope. 
 
 
5.10 Immunohistochemistry of the intestine 
 
Dissected duodenal samples from 8-week old control mice or P5 Trpm7 fl/fl; Villin1-Cre and Trpm7 fl/fl 
mice were fixed in 4% (w/v) PFA in 1x PBS for 2 h (RT). After incubation in 1x PBS for 1 h (RT), 
tissues were incubated for 24 h (4 °C) in 18% sucrose in 1x PBS. Next, tissues were embedded in 
Jung tissue freezing medium. Cryosections (16 μm) were produced by CM 3050S cryotome, 
mounted on Superfrost Plus slides and air-dried for 20 min (RT). Sections were washed in 1x PBS 
(3x 5 min, RT) and blocked in 1x PBS supplemented with 10% goat serum, 3% BSA and 0.3% 
Triton X-100 (blocking solution) for 1 h (RT). The rabbit anti-TRPM7 antibody AB15562 was 
incubated overnight in blocking solution (4 °C). Sections were washed in 1x PBS containing 0.05% 
Tween 20 (TBST, 3x 5 min, RT) and 1 μg/ml of Alexa Fluor 488 goat anti-rabbit antibody was 
applied in 1x PBS containing 0.02 % sodium acid (m/v) and 0.5 % lambda-Carrageenan (m/v) for 
2h (RT). After washing in PBST (3x 5 min, RT), slides were stained with Hoechst 33342 in PBST 
(10 µg/ml) and embedded in Dako Fluorescent Mounting Medium. Confocal images and differential 
interference contrast (DIC) were obtained by a confocal laser scanning microscope (LSM 880 
AxioObserver). A C-Apochromat 63x/1.2 W objective, 410–501 nm and 493–630 nm filters and 
405 nm and 488 nm excitation wavelengths were used. Images were analyzed by the ZEN2.3 
software. 
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5.11 Statistical analysis 
 
Otherwise indicated differently, data were analyzed using Excel 2010 (Microsoft 2007 Professional) 
and presented as mean value ± standard error of the mean (SEM). Statistical analysis was 
conducted using Student’s t-test (two-tailed distribution, two-sample equal variance).  
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6 Results 
 
6.1. Assessment of the TRPM7 function in cultured cells 
 
One of the main goals of this thesis was to investigate whether the TRPM7 channel is capable to 
regulate cellular levels of divalent cations. To avoid pitfalls often caused by overexpression of the 
recombinant ion channels, we studied a human haploid leukemia (HAP1) cell line carrying a loss-
of-function mutation in the TRPM7 gene. HAP1 cells are haploid and well accessible to 
CRISPR/Cas9-mediated mutagenesis [138, 139]. As reported previously [44], the TRPM7-deficient 
HAP1 cells lack endogenous TRPM7 currents. In addition, the TRPM7-deficient HAP1 cells 
displayed a proliferation defect when cultured in a regular cell culture medium, recapitulating the 
phenotype of other Trpm7 gene-deficient cell lines, such as the chicken B lymphoma cell line DT-40 
[17], mouse embryonic stem cells [43] and trophoblast stem cells [6, 44] derived from Trpm7-
deficient embryos. In line with other TRPM7-deficient cell lines, the proliferation arrest of HAP1 
cells could be rescued by addition of 10 mM Mg2+ in the culture medium [6, 17, 44], supporting the 
idea that the TRPM7 channel is required for the cellular balance of Mg2+. 
In the present study, we asked whether TRPM7 is required to maintain the cellular content of other 
divalent cations including Ca2+ and Zn2+. Total cellular levels of Mg2+ are in the range of 5–10 mM, 
while cytosolic free Mg2+ only amounts to 0.5–1 mM, since ~90% of Mg2+ is bound to ATP and other 
metabolites [42]. Cytosolic levels of free Ca2+ are in the range of 50–100 nM, whereas the total 
content of Ca2+ is ~1 mM [140]. Zn2+ content in cells was estimated to be in the range of 10–
100 µM, whereas the cytosolic concentration of free Zn2+ is in the pico- to low nano-molar range 
because most Zn2+ is bound to proteins [115]. Hence, free cytosolic concentrations of a particular 
divalent cation may not be reliably used to score changes in the cellular balance of this cation. To 
address a role of TRPM7, we opted for inductively coupled plasma mass spectrometry (ICP-MS), 
an analytical method well suitable to study total cellular levels of divalent and monovalent cations 
[136, 137]. 
In our experimental settings, TRPM7 KO and WT (parental) cells were cultured in a medium 
containing additional Mg2+ (10 mM Mg2+). 24 h prior ICP-MS analysis, the medium was replaced by 
a fresh regular medium (without additional Mg2+). After 24 h, we collected the cells, obtained dried 
cell pellets and conducted ICP-MS analysis. We found that TRPM7 HAP1 KO cells were depleted 
in Mg (12%) and Zn (7%). Cellular Ca showed a tendency to reduction (11%), but this difference 
was not statistically significant (Figure 5).  
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Figure 5: Determination of elementary levels of divalent cations in WT and TRPM7 KO HAP1 cells. 
Total contents of Ca (left panel), Mg (middle panel) and Zn (right panel) were determined using ICP-MS and 
normalized to dry cell pellet weight (mean ± SEM); *** - P≤0.001; ** - P≤0.01; n.s. - not significantly different 
(Student’s t-test). n - number of independent measurements. 
 
 
To further verify the impact of the loss-of-function mutation in TRPM7 on the cellular balance of 
divalent cations, we determined ratios of individual divalent cations to total content of sulfur (Figure 
6 A, as a proxy for total content of proteins and amino acids), rubidium (Figure 6 B, as a proxy for K 
with less prone to environmental contamination) and phosphorus (Figure 6 C, as a proxy for total 
contents of DNA, RNA and nucleotides). This analysis was in line with our previous conclusions 
that TRPM7-deficient cells contained less Mg and Zn (Figure 5). Taken together, our results 
suggest that TRPM7 HAP1 KO cells are deficient in Mg and Zn. 
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Figure 6: Relative levels of Ca, Mg and Zn in WT and TRPM7 KO HAP1 cells. Total elementary contents 
of divalent metals shown in Figure 5 were normalized to total elementary contents of (A) sulfur (S), (B) 
rubidium (Rb) and (C) phosphorus (P). Results are represented as mean ± SEM. *** - P≤0.001; ** - P≤0.01; 
n.s. - not significantly different (Student’s t-test). n - number of independent measurements. 
 
 
While a role of TRPM7 in maintaining the cellular Mg2+ homeostasis is well documented in the 
literature [6, 17, 43, 44], our finding that TRPM7-deficient cells display reduced Zn2+ levels was 
rather unexpected. Therefore, we asked whether, similar to the situation with Mg2+ deprivation in 
TRPM7 KO cell lines [17, 44], Zn2+ deficiency in TRPM7 KO HAP1 cells can be ameliorated by the 
addition of exogenous Zn2+ to the cell culture medium. We added 50 µM Zn2+ to the regular medium 
(containing ~3 µM Zn2+), incubated the cells for 24 h in this medium, and analyzed the dried cell 
pellets using ICP-MS. We found that Zn contents were increased in both WT and TRPM7 KO HAP1 
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cells maintained in the Zn2+-supplemented medium (Figure 7), suggesting that additional Zn2+ 
uptake mechanisms exist in HAP1 cells. Furthermore, we observed that total Zn levels in control 
and TRPM7-deficent cells treated with Zn2+-enriched medium were equal. 
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Figure 7: Determination of elementary Zn levels in WT and TRPM7 KO HAP1 cells grown in Zn 
enriched medium. Dried cell pellets were obtained from WT and KO HAP1 cells cultured in a standard cell 
culture medium or in a medium containing additional 50 µM ZnSO4 for 24 h and analyzed by ICP-MS. Total 
elementary Zn contents were normalized to dry pellet weight and represented as mean ± SEM; ** - P≤0.01; * 
- P≤0.05; n.s. - not significantly different (One-Way ANOVA); n - number of independent measurements. 
 
 
Next, we investigated whether inactivation of TRPM7 in HAP1 cells will reduce the uptake of 
radioactive 65Zn2+ in resting cells kept in saline containing physiological levels of divalent cations. 
We incubated TRPM7 HAP1 KO and WT cells in a buffer containing Mg2+ (1 mM), Ca2+ (2 mM) and 
65Zn2+ (2 µM) and determined the time-dependent 65Zn2+ accumulation. The datasets were fitted by 
a one-phase exponential association equation. TRPM7-deficient HAP1 cells were characterized by 
a downward shift of 65Zn2+ uptake rate when compared to WT cells (P=0.0005, F-test) (Figure 8). 
The rate constant (K) was not altered (P=0.72, F-test), but the maximum 65Zn2+ uptake at 
equilibrium (Bmax) was significantly decreased in TRPM7 HAP1 KO cells (P=0.0017, F-test). These 
data suggest that native TRPM7 regulates Zn2+ uptake in resting cells in the presence of 
physiological concentrations of Ca2+ and Mg2+. 
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Figure 8: Assessment of 
65
Zn
2+ 
uptake in HAP1 WT and TRPM7 KO cells. HAP1 WT and TRPM7-
deficient HAP1 KO cells were incubated in the presence of 2 µM 
65
Zn
2+
, 1 mM Mg
2+
 and 2 mM Ca
2+
. The 
time-dependent accumulation of 
65
Zn
2+
 was determined. The results (mean ± SEM) were fitted by one-phase 
exponential association equation; *** - P≤0.001 (One-Way ANOVA); n - number of independent 
measurements. 
 
 
Collectively, our results support the notion that TRPM7 regulates the uptake of Zn2+ and Mg2+ on a 
cellular level. 
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6.2 Strategy for the evaluation of TRPM7’s function on organismal mineral homeostasis  
 
As TRPM7 plays a critical role in cellular homeostasis of divalent cations, we asked whether 
TRPM7 regulates the transport of divalent metals in epithelial cells of the kidney and the intestine. 
To address this question, we generated new mouse strains with mutations resulting in organ-
specific deletion of TRPM7. We used a mouse strain carrying two intronic LoxP sites flanking 
exon 17 of the Trpm7 gene (Trpm7 fl) (Figure 9 A) [59]. Deletion of exon 17 by a Cre recombinase 
results in a frame-shift mutation (Trpm7 Δ17 allele) (Figure 9 A) disrupting the TRPM7 channel and 
the kinase activity [59]. For inactivation of Trpm7 specifically in the intestinal and renal epithelium, 
Trpm7 fl/fl mice were crossed with Villin1-Cre and Ksp1.3-Cre transgenic mice. Villin1-Cre is 
expressed in the enterocytes of the whole intestine starting from embryonic day 12.5 [134] and is 
frequently used for a constitutive deletion of floxed alleles in this organ. Pioneering studies 
proposed the concept that the final urinary content of Ca2+ and Mg2+ is determined by the distal 
convoluted tubule (DCT) of the kidney. Accordingly, DCT may play a critical role in the whole-body 
balance of divalent cations [76, 141]. Since there is no Cre transgene available only active in DCT 
cells, Ksp1.3-Cre transgenic mice are used for deletion of floxed alleles in this field [135], because 
Ksp1.3-Cre drives expression of Cre in the epithelial cells of collecting duct, DCT and thick 
ascending limb of Henle. Consequently, our breeding of Trpm7 fl/fl with Villin1-Cre and Ksp.1.3-Cre 
transgenic mice resulted in offspring, which presumably lacked TRPM7 protein specifically in the 
intestinal and the renal epithelium referred to Trpm7 Intestine KO (Figure 9 B) and Trpm7 Kidney KO 
(Figure 9 C), respectively. 
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epithelial, renal KO of Trpm7
Floxed allele (fl) 16 1817 LoxPLoxP
Null allele (∆17) 16 18LoxP
WT allele (+) 16 1817
Cre recombinase
A
B C 
 
Figure 9: Genetic strategy used for a conditional inactivation of Trpm7 in mice. (A) Exon 17 of Trpm7 
was flanked by two intronic LoxP sites. Deletion of exon 17 by a Cre recombinase results in a null allele [59]. 
(B) Villin1-Cre and (C) Ksp1.3-Cre transgenes enable to delete exon 17 in Trpm7, respectively, in epithelial 
cells of the intestine (B) and kidney (C). 
 
 
To investigate the impact of TRPM7 kinase, we used a previously-established mouse strain 
carrying a ‘kinase-dead’ point mutation in the Trpm7 gene resulting in complete inactivation of the 
kinase activity in the whole body (Trpm7 ki/ki mice) [65]. Specifically, thymine (T) was replaced by 
cytosine (C) in exon 33 of Trpm7 [65] (Figure 10). As a consequence, the mutant locus expresses 
TRPM7 containing the point mutation K1646R (Figure 10). K1646 is required for binding of ATP in a 
catalytic site of TRPM7 kinase domain. K1646R mutation does not interfere with the TRPM7 
channel function but blocks completely phosphotransferase activity of the kinase domain [65]. 
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wt sequence mutant
 
Figure 10: Sequencing of WT and ‘kinase-dead’ KI locus in Trpm7. A point mutation in the Trpm7 gene 
exchanges thymine (T) to cytosine (C). Consequently, arginin (Arg) is introduced instead of lysin (Lys) in 
mouse TRPM7 (K1646R) (modified from Ryazanova et al., 2014 [66]). 
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6.3 Assessment of mice lacking TRPM7 in the kidney 
 
To produce kidney-specific inactivation of TRPM7, we crossed Trpm7 fl/fl and Ksp1.3-Cre transgenic 
mice. To verify genotypes of the offspring, we performed a PCR specific for the Ksp1.3-Cre 
transgene (Figure 11). To confirm that mice are homozygous for the Trpm7 fl allele (Table 46), a 
PCR specific for the Trpm7 wt allele was performed as outlined below (Figure 16). 
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Ksp1.3-
Cre
wt H2O
 
Figure 11: Genotyping of mice carrying the Ksp1.3-Cre transgene. Genomic DNA obtained from tail 
fragments of Ksp1.3-Cre transgenic mice was analyzed by PCR approach using primers specific for Ksp1.3-
Cre sequence. The PCR amplicon (420 bp) was examined using agarose gel electrophoresis. H2O and 
genomic DNA from wt mice were used to verify the specificity of the PCR. 
 
 
Trpm7 Kidney KO mice were born in the expected Mendelian ratio (Table 46) and showed no obvious 
changes in growth, survival, fertility and physical appearance during 18 months of life (Figure 12). 
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Figure 12: Body weight and survival rate of control and Trpm7 
Kidney KO
 mice. (A) Body weight of 8 weeks 
old control and Trpm7 
Kidney KO
 mice. (B) Trpm7 
Kidney KO
 mutation did not induce mortality in the mutant mice 
during 8 weeks of postnatal life. Values are mean ± SEM; n.s. - not significantly different (Student’s t-test); n - 
number of mice. 
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To examine the expression of Trpm7 in the kidney and to verify the deletion of the floxed sequence 
in Trpm7 Kidney KO animals, we first tested a set of commercial and custom-made anti-TRPM7 
antibodies. However, all reagents failed to detect TRPM7 protein in the kidney. Therefore, we used 
in situ hybridization. In line with previous studies [10, 142, 143], we could observe that Trpm7 was 
abundantly expressed in tubule segments of control kidneys, characterized by apically located cell 
nuclei, a characteristic feature of DCT cells (Figure 13). Furthermore, Trpm7 mRNA was not 
detectable in these epithelial cells in Trpm7 Kidney KO animals indicating that deletion of Trpm7 was 
efficient. Importantly, we did not observe morphological alterations in mutant kidneys, suggesting 
that morphogenesis was not affected in Trpm7 Kidney KO mice (Figure 13). 
 
 
Kidney KOControl
50µm 50µm
 
Figure 13: Detection of Trpm7 transcripts in the kidney of control and Trpm7 
Kidney KO
 mice. Expression 
of Trpm7 was examined using in situ hybridization (ISH) in kidney sections of 8 weeks old control and 
Trpm7 
Kidney KO
 mice. Expression of Trpm7 was detected in nephron segments resembling distal convoluted 
tubule (DCT) in control mice (Control, red arrows). This Trpm7 signal was absent in DCT in tissues of 
Trpm7 
Kidney KO
 mice (Kidney KO, red arrows). Representative images are shown (n=2 tissues per genotype). 
 
 
Next, we asked whether the kidney-specific inactivation of TRPM7 can impact renal reabsorption of 
divalent cations. We collected urine and serum samples from 8 weeks old mice and examined 
these samples using ICP-MS. However, we found no changes in Ca2+, Mg2+ and Zn2+ levels in urine 
or serum (Figure 14), suggesting that homeostasis of divalent cations was normal in Trpm7 Kidney KO 
mice. 
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Figure 14: Assessment of elementary levels of divalent cations in serum and urine of control and 
Trpm7 
Kidney KO
 mice. Levels of Ca (left panels), Mg (middle panels) and Zn (right panels) were examined in 
serum (A) and urine (B) in 8 weeks old control and Trpm7 
Kidney KO
 mice using ICP-MS. Values are shown as 
mean ± SEM; n.s. - not significantly different (Student’s t-test); n - number of mice. 
 
 
To elucidate whether TRPM7 function was compensated by other proteins, we analyzed genes 
which are thought to be involved in renal reabsorption of Mg2+ (Claudin-16 and Trpm6) [144, 145], 
Ca2+ (Trpv5) [146] and Zn2+ (ZnT1 and ZnT2) [147] using qRT-PCR. However, we did not observe 
differences in mRNA levels of these genes (Figure 15). 
To summarize, Trpm7 is highly expressed in the DCT segment of the kidney but the Ksp1.3-Cre-
mediated inactivation of TRPM7 has no impact on the organismal balance of divalent cations. 
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Figure 15: Expression of Trpm6, Claudin-16, Trpv5, ZnT1 and ZnT2 in the kidney of control and 
Trpm7 
Kidney KO
 mice. mRNA levels of Trpm6, Claudin-16, Trpv5, ZnT1 and ZnT2 in kidneys of control and 
Trpm7 
Kidney KO
 mice were measured using qRT-PCR and Ywhaz as the reference gene. Values are mean ± 
SEM; n.s. - not significantly different (Student’s t-test); n - number of mice. 
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6.4 Examination of mice lacking TRPM7 in the intestine 
 
6.4.1 Genetic and phenotypical assessment of Trpm7 Intestine KO mice  
 
To produce mice carrying an intestinal-specific inactivation of TRPM7, we crossed Trpm7 fl/fl and 
Villin1-Cre transgenic mice. To verify genotypes of the offspring, we performed a set of PCRs 
specific for Villin1-Cre transgene, as well as for wt and floxed Trpm7 alleles (Table 46) (Figure 16).  
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fl/wt fl/fl H2O
BA
 
Figure 16: Genotyping of Villin1-Cre, Trpm7 
fl/wt
 and Trpm7 
fl/fl
 transgenic mice. (A, B) Genomic DNA 
obtained from tail fragments of Villin1-Cre, Trpm7 
fl/wt
 and Trpm7 
fl/fl
 transgenic mice was analyzed by PCR 
approach using primers specific for Villin1-Cre and Trpm7 
wt
 sequence. The PCR amplicons (195 bp for 
Villin1-Cre (A) and 530 bp for Trpm7 
wt 
(B)) were examined using agarose gel electrophoresis. H2O and 
genomic DNA from wt and fl mice were used to verify the specificity of the PCR. 
 
 
Trpm7 Intestine KO mice were born in the expected Mendelian ratio (Table 46). At the day of birth 
(postnatal day 1, P1), Trpm7 Intestine KO mice displayed a normal body weight and overall physical 
appearance as compared to control littermates (Figure 17 A, C). At P3 and P5, the mutants were 
growth delayed (respectively, 12% and 45%) (Figure 17 B, C). Furthermore, P3–5 Trpm7 Intestine KO 
mice showed a high mortality rate and all Trpm7 Intestine KO individuals have died after P10 (Figure 17 
D). Importantly, stomachs of P1–10 Trpm7 Intestine KO mice were filled with milk, a sign for normal 
feeding behavior. 
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Figure 17: Physical appearance of control and Trpm7 
Intestine KO
 mice. Trpm7 
Intestine KO
 mice were not 
distinguishable from control littermates at postnatal day 1 (P1) (A), whereas growth retardation was observed 
in the mutant pups at P5 (B). Body weight (mean ± SEM) (C) and survival rate (D) of control and 
Trpm7 
Intestine KO
 mice. *** - P≤0.001, * - P≤0.05, n.s. - not significantly different (Student’s t-test); n - number of 
mice. 
 
 
It was shown that an early embryonic inactivation of Trpm7 affects morphogenesis of several 
organs [59, 61, 62, 148]. Therefore, we asked whether villi of Trpm7 Intestine KO mice were normally 
developed. We isolated villi from the whole intestine of P5 littermates and examined them using a 
microscope. Villi isolated from Trpm7 Intestine KO mice showed no obvious morphological alterations 
(Figure 18). Next, we isolated villi RNA and examined the expression of Villin1, a marker of 
differentiated intestinal enterocytes [134]. We found no changes in relative expression levels of 
Villin1 (Figure 19). 
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Figure 18: Representative images of purified villi isolated from control and Trpm7 
Intestine KO
 mice.
 
 
 
To verify the efficiency of recombination in the Trpm7 fl allele, we assessed the villi RNA samples 
using qRT-PCR specific for WT Trpm7 transcripts. WT Trpm7 transcripts were nearly undetectable 
in the villi from Trpm7 Intestine KO mice (Figure 19), suggesting that Villin1-Cre was highly efficient in 
mutagenesis of Trpm7 fl. 
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Figure 19: Relative expression levels of Trpm7 and Villin1 in the villi of control and Trpm7 
Intestine KO
 
mice. mRNA expression of Trpm7 (left) and Villin1 (right) was analyzed using qRT-PCR and Hprt as a 
reference transcript. Values are shown as mean ± SEM; *** - P≤0.001, n.s. - not significantly different 
(Student’s t-test); n - number of mice. 
 
 
The deletion of TRPM7 in the intestinal enterocytes of Trpm7 Intestine KO mice was further verified by 
immunofluorescence staining with TRPM7-specific antibody of duodenal sections (Figure 20). We 
observed a staining of the apical surface of villus cells in tissues isolated from 8 weeks old control 
mice. However, the signal was significantly reduced in tissues from P5 control mice, suggesting 
that expression levels of TRPM7 are lower in newborn mice as compared to adult animals (Figure 
20). Importantly, in line with qRT-PCR data (Figure 19), villus epithelial cells in tissues from P5 
Trpm7 Intestine KO mice were not labeled (Figure 20), confirming the successful deletion of TRPM7 in 
the intestinal enterocytes of Trpm7 Intestine KO mice. 
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Figure 20: Staining of duodenum sections using a TRPM7-specific antibody. TRPM7 immunoreactivity 
(TRPM7), Hoechst staining (Hoechst) and differential interference contrast images (DIC) are shown. Tissue 
sections were obtained from duodenums of 8 weeks old or P5 control and P5 Trpm7 
Intestine KO
 mice. Triangles 
show labeling of the apical surface of enterocytes, which was observed in control tissues only. 
Representative images are shown (n = 2 tissues per genotype). 
 
 
To get insights whether tissue homeostasis was affected in the intestine of Trpm7 Intestine KO mice, we 
investigated the duodenum of P5 mutant and control littermates (duodenum is thought to be very 
active in nutritional intake of Ca2+ and Zn2+ [93, 119-121]). We extracted RNA from the whole 
duodenum and investigated relative expression levels of different markers. We found no changes in 
expression levels of Villin1, Dclk1, Lgr5 and Muc2, markers of enterocytes, tuft cells, intestinal stem 
cells and goblet cells (Figure 21). In contrast, expression of Lyz1, a marker for Paneth cells [149], 
was elevated 3.65 times (Figure 21). 
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Figure 21: Relative expression levels of cell-type markers in the intestine of control and 
Trpm7 
Intestine KO
 mice. mRNA levels of Villin1 (enterocytes), Muc2 (goblet cells), Lgr5 (intestinal stem cells), 
Dclk1 (tuft cells) and Lyz1 (Paneth cells) were analyzed in the duodenum of P5 animals using qRT-PCR and 
Hprt as a reference transcript. Values are shown as mean ± SEM; ** - P≤0.01, n.s. - not significantly different 
(Student’s t-test); n - number of mice. 
 
 
Finally, we performed a histological examination of the small and large intestine of Trpm7 Intestine KO 
individuals at P1. Examination of hematoxylin and eosin (H&E) stained tissue sections did not 
reveal systemic abnormalities with regard to gross anatomy and overall mucosal architecture 
indicating unaffected intestinal organogenesis. However, we observed some duodenal erosions 
and vacuolization of epithelial crypt cells of the jejunum (Figure 22) resembling the phenotype of 
Trpm7-deficient vacuole-rich megakaryocytes [63]. In addition, vacuolization of cells was observed 
in the enterocytes of rodents maintained on a Zn2+-deficient diet [150, 151]. Taken together, our 
results suggest that the conditional mutagenesis of Trpm7 in intestinal enterocytes didn’t affect the 
embryonic morphogenesis of the intestine. 
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Figure 22: Histological examination of the intestine of control and Trpm7 
Intestine KO
 mice. Hematoxylin 
and eosin (H&E) staining of paraffin-embedded tissue sections (duodenum, jejunum, ileum and colon) of P1 
control and Trpm7 
Intestine KO 
littermates. Representative images are shown (n=3 tissues per genotype). The 
triangle points at duodenal erosion observed in the duodenum of Trpm7 
Intestine KO
 mice. Arrows indicate 
vacuolization of cells in the jejunum of Trpm7 
Intestine KO
 mice. 
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6.4.2 Assessment of divalent cation homeostasis in mice lacking intestinal TRPM7  
 
We asked whether the ablation of TRPM7 in Trpm7 Intestine KO pups could trigger malabsorption of 
divalent cations. We used ICP-MS to analyze levels of main minerals in serum and bones (right 
tibia) of Trpm7 Intestine KO pups prior to (P1) or at the onset (P3, P5) of macroscopic phenotypes 
(Figure 17). We found no changes in concentrations of Ca, Mg or Zn in P1 Trpm7 Intestine KO mice 
(Figure 23). Interestingly, in the follow-up period, Trpm7 Intestine KO mice developed deficiencies of 
divalent cations. At P3 we observed that Mg levels were not changed, but at P5 we found a 
statistically significant reduction of Mg content (22%) in serum as compared to control values 
(Figure 23 A). However, Mg levels of bones at P3 and P5 were normal, indicating that the 
Trpm7 Intestine KO mice developed a rather moderate Mg2+ deficiency at P5 (Figure 23 B). In contrary, 
Ca homeostasis was stronger affected since a significant reduction of Ca concentration in the 
serum (14%) of Trpm7 Intestine KO mice was observed already at P3, which was more pronounced at 
P5 (36%) (Figure 23 A). In line with these alterations, only P5 Trpm7 Intestine KO mice displayed a 
significant depletion (19%) of Ca in bones (Figure 23 B). Notably, Zn homeostasis was most 
strongly affected in Trpm7 Intestine KO pups. Serum Zn concentrations were 21% and 61% decreased 
in Trpm7 Intestine KO pups at P3 and P5, respectively (Figure 23 A). In bones, Zn concentrations were 
not affected in P3 Trpm7 Intestine KO mice, however, Zn content was lower (18%) in P5 mutants 
(Figure 23 B). 
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Figure 23: Assessment of elementary levels of divalent cations in control and Trpm7 
Intestine KO
 mice. 
ICP-MS analysis of elementary levels of Ca (left panels), Mg (middle panels) and Zn (right panels) in serum 
(A) and bones (right tibia) (B) of P1, P3 and P5 control and Trpm7 
Intestine KO
 littermates. Results are shown as 
mean ± SEM; *** - P≤0.001, ** - P≤0.01, * - P≤0.05, n.s. - not significantly different (Student’s t-test); n - 
number of mice. 
 
 
Importantly, concentrations of monovalent cations such as sodium (Na) and potassium (K) were not 
altered, neither in bones nor in serum of P1–5 Trpm7 Intestine KO pups (Figure 24), except a slight 
elevation (24%) of Na levels in bones of P5 mutants. These results indicate that the lack of TRPM7 
in the intestine caused only a defect in the uptake of divalent cations. 
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Figure 24: Elementary levels of monovalent cations in control and Trpm7 
Intestine KO
 mice. ICP-MS 
analysis of elementary levels of Na (left panels) and K (right panels) in serum (A) and bones (right tibia) (B) 
of P1, P3 and P5 control and Trpm7 
Intestine KO
 littermates. Values are mean ± SEM; ** - P≤0.01, n.s. - not 
significantly different (Student’s t-test); n - number of mice. 
 
 
6.4.3 Evaluation of organismal adaptive response of Trpm7 Intestine KO mice  
 
Since we have found reduced Ca levels in serum and bones of Trpm7 Intestine KO mice, we asked 
whether this deficiency triggered an organismal adaptive response. Parathyroid hormone (PTH) 
and calcitriol (1,25-(OH)2D3) are two important regulators of Ca
2+ homeostasis [152, 153]. It is well 
documented that a release of PTH and 1,25-(OH)2D3 is enhanced by low serum Ca
2+ [152, 153]. To 
examine whether serum PTH and 1,25-(OH)2D3 levels were increased in Trpm7 
Intestine KO mice we 
used an ELISA. As expected, Trpm7 Intestine KO mice displayed increased circulating levels of PTH 
(18.2-fold, Figure 25 A) and calcitriol (1,25-(OH)2D3) (9.4-fold, Figure 25 B).  
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Figure 25: Parathyroid hormone (PTH) and calcitriol (1,25-(OH)2D3) levels in serum of control and 
Trpm7 
Intestine KO
 mice. The concentration of PTH (A) and calcitriol (1,25-(OH)2D3) (B) in serum of P5 control 
and Trpm7 
Intestine KO
 animals were measured using an ELISA. (A) Note: only two samples from 
Trpm7 
Intestine KO
 mice were above the assay sensitivity level of the PTH ELISA (0.425 pM) and statistical 
analysis could not be performed. (B) The results are shown as mean ± SEM; *** - P≤0.001 (Student’s t-test); 
n - number of mice. 
 
 
It is known that PTH increases the activity of cytochrome P450 27b1 (Cyp27b1), the enzyme of the 
kidney controlling hydroxylation of inactive calcifediol (inactive form of vitamin D) to calcitriol (active 
form of vitamin D). Therefore, we studied whether Cyp27b1 expression in the kidney was changed 
in Trpm7 Intestine KO mice. As expected, Cyp27b1 mRNA was strongly upregulated (32.4-fold, Figure 
26 A). It was suggested that calcitriol increases the uptake of Ca2+ by the gastrointestinal tract due 
to upregulation of the Ca2+ selective channel Trpv6 and Ca2+-binding protein Calbindin-D9k. We 
found that expression levels of Trpv6 and Calbindin-D9k were significantly upregulated in the 
duodenum of Trpm7 Intestine KO mice, 7.4-fold and 4.1-fold respectively (Figure 26 B). 
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Figure 26: Evaluation of intestinal expression of Ca related genes in control and Trpm7 
Intestine KO
 mice. 
mRNA levels of Cyp27b1 in the kidney (A) and Trpv6 and Calbindin-D9k in the duodenum (B) of P5 animals 
were analyzed using qRT-PCR and Hprt as a reference transcript. Values are shown as mean ± SEM; ** - 
P≤0.01, * - P≤0.05 (Student’s t-test); n - number of mice. 
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Thus, Trpm7 Intestine KO mice displayed a remarkable adaptive response secondary to Ca2+ 
deficiency. 
Organismal response to Mg2+ or Zn2+ deficiency remains poorly understood. A previous study has 
shown that Trpm6 controls intestinal Mg2+ uptake [44]. Accordingly, Trpm6 KO mice develop 
systemic Mg2+ deficiency [44] accompanied by low circulating levels of insulin-like growth factor 1 
(IGF1). Therefore, we assessed the expression of Trpm6 in the duodenum of P5 Trpm7 Intestine KO 
mice and found that Trpm6 mRNA levels were 30.0-fold increased (Figure 27). Additionally, two 
putative intestinal Mg2+ transporters, Slc41a1 and Slc41a2, were upregulated (113% and 94%, 
respectively) (Figure 27).  
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Figure 27: Intestinal expression of genes related to Mg homeostasis in control and Trpm7 
Intestine KO
 
mice. mRNA levels of Trpm6, Slc41a1 and Slc41a2 were analyzed in the duodenum of P5 animals using 
qRT-PCR and Hprt as a reference transcript. Values are shown as mean ± SEM; *** - P≤0.001, ** - P≤0.01, * 
- P≤0.05 (Student’s t-test); n - number of mice. 
 
 
In addition, we found that serum IGF1 concentration was substantially lower (70%) in 
Trpm7 Intestine KO mice at P5 using an ELISA (Figure 28 A). Thyroxine (T4) was suggested to be linked 
to a thyroid gland response to low levels of Zn2+ in the body [154]. Therefore, we investigated 
serum T4 levels in P5 littermates using ELISA and found that Trpm7 
Intestine KO pups developed 
hypothyroidism: T4 concentration was 55% reduced (Figure 28 B). 
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Figure 28: Insulin-like growth factor 1 (IGF1) and thyroxine (T4) levels in serum of control and 
Trpm7 
Intestine KO
 mice. The concentration of insulin-like growth factor 1 (IGF1) (A) and Thyroxine (T4) (B) in 
serum of P5 control and Trpm7 
Intestine KO
 animals was measured using an ELISA. The results are shown as 
mean ± SEM; *** - P≤0.001 (Student’s t-test); n - number of mice. 
 
 
Next, we asked whether mRNA levels of Zn2+-inducible genes were changed. Since the duodenum 
is regarded as the main site for intestinal uptake of Zn2+ [119-121], we isolated RNA from the whole 
duodenum, and examined relative expression levels of known Zn2+ transporters from the Slc30 and 
the Slc39 gene families as well as metallothionein (MT1), the main intracellular scavenger of Zn2+ 
ions. mRNA levels of ZnT1, ZnT2, Zip4 and Zip5 were significantly downregulated, whereas MT1 
was upregulated and ZnT4 unchanged in Trpm7 Intestine KO mice. Taken together, the epithelial 
transport of Zn2+, Mg2+ and Ca2+ is profoundly dysregulated in Trpm7 Intestine KO mice followed by 
induction of a strong organismal response. 
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Figure 29: Relative expression levels of Zn transporters and MT1 in the intestine of control and 
Trpm7 
Intestine KO
 mice. mRNA levels of ZnT1, ZnT2, ZnT4, Zip4, Zip5 and MT1 in the duodenum were 
measured using qRT-PCR and Hprt as a reference transcript. The results are shown as mean ± SEM; *** - 
P≤0.001, ** - P≤0.01, * - P≤0.05, n.s. - not significantly different (Student’s t-test); n - number of mice. 
 
 
6.4.4. Supplementation of Trpm7 Intestine KO mice with high doses of Mg2+, Ca2+ and Zn2+ 
 
Mg2+- and Ca2+-rich diets were found to be affective in counteracting the deficiency of Mg2+ and 
Ca2+ in adult mice [42, 44, 86, 115]. We investigated whether the high mortality of newborn 
Trpm7 Intestine KO mice can be ameliorated by dietary supplementation of Ca2+, Mg2+ or Zn2+. Since 
newborn pups are breastfed for the first 3 weeks of postnatal life, the breeding females were 
treated with the different diets during pregnancy and breastfeeding of the offspring (Table 63). 
Specifically, we used chows with 2% Ca2+ (1% in the normal diet) or with 0.75% Mg2+ (0.22% in the 
normal diet). For Zn2+ supplementation, we dissolved ZnSO4 * 7 H2O in deionized water (dH2O) 
(0.1%), since this strategy was used before to rescue Zn2+ deficient animals [155]. The “high Zn 
diet” and the untreated KO group received the regular Ssniff M-Z as chow (Table 63). 
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Table 63: Dietary treatments used in survival experiments 
Group Chow Drinking water 
Control diet Regular chow dH2O 
High Mg diet High Mg2+ chow dH2O 
High Ca diet High Ca2+ chow dH2O 
High Zn diet Regular chow dH2O + 0.1% Zn
2+ 
Triple diet 
(high Mg, Ca and Zn) 
High Ca2+/Mg2+ chow dH2O + 0.1% Zn
2+ 
 
 
We determined the survival rates of Trpm7 Intestine KO mice in the untreated and supplemented 
groups. None of the Trpm7 Intestine KO pups from the untreated group could survive after P14 (Figure 
30). Although animals of the “high Ca diet” had a 3-day delay in the onset of mortality, the lifespan 
was not significantly increased (P=0.31) in this group (Figure 30 A). Interestingly, the survival curve 
of the “high Zn diet” group was rightward shifted (P < 0.0001). Remarkably, at P7 only 18% of 
mutant pups were dead in this group vs 69% in the untreated group. Two Trpm7 Intestine KO mice of 
the “high Zn diet” survived to weaning (Figure 30 C) and had to be euthanized afterwards at P23 
and P33, respectively. Weaned Trpm7 Intestine KO mice were smaller in size compared to control 
littermates (Figure 30 D). Mg2+ supplementation was also beneficial for the survival rate of 
Trpm7 Intestine KO offspring (P = 0.014) (Figure 30 B). The onset of mortality was significantly delayed. 
Furthermore, one Mg2+-treated mutant was viable at weaning and died at P37. 
Importantly, during ~5 years of production of Trpm7 Intestine KO offspring on the regular diet, no single 
individual could survive till weaning, further reinforcing the positive outcome of dietary Zn2+ and 
Mg2+ treatments. Thus, nutritional supplementation by Zn2+ and to a less degree by Mg2+ extended 
the lifespan of Trpm7 Intestine KO animals. 
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Figure 30: Survival rates of control and Trpm7 
Intestine KO
 animals fed with control vs high Ca
2+
, Mg
2+
, 
Zn
2+
 and triple diet. Breeding pairs (♀Trpm7 
fl/fl
 x ♂ Trpm7 
fl/wt
; Villin1-Cre) were maintained on either a 
control diet (A-C) or a high Ca
2+
 (A), Mg
2+
 (B), Zn
2+
 or triple (C) diet. For statistical analysis each 
experimental group was compared to the control group using log-rank test. (D) Representative image of 
surviving P33 Trpm7 Intestine KO mouse and a corresponding control littermate maintained at high Zn2+ diet; n - 
number of mice. 
 
 
Next, we asked whether a combined diet with high levels of Zn2+, Ca2+ and Mg2+ can improve the 
survival rate of mutant mice (Table 63). However, the combined diet did not extend the lifespan of 
Trpm7 Intestine KO animals beyond that one displayed by the Zn2+-treated group (with 1 animal 
survived to weaning and died at P21). These findings suggest that Zn2+ deficiency underlies the 
mortality of Trpm7 Intestine KO mice and that additional dietary Mg2+ and Ca2+ could not circumvent this 
outcome. 
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6.4.5 Analysis of transcriptional changes of Trpm7 Intestine KO mice 
 
To get an unbiased insight into cellular processes affected in the intestine of Trpm7 Intestine KO mice, 
we isolated RNA from the villi of P5 Trpm7 Intestine KO and control littermates and performed a 
genome-wide transcriptome profiling using gene microarray approach (NCBI Gene Expression 
Omnibus (GEO), GSE110613). Using a 2-fold change cut-off value with P ≤ 0.05 for the false 
discovery rate (FDR), we found 455 genes up- or downregulated in the Trpm7 Intestine KO mice (list of 
regulated genes can be found at https://www.pnas.org/content/early/2019/02/14/1810633116/tab-
figures-data, Dataset S02). Using the Ingenuity Pathway Analysis (IPA), we figured out that gene 
networks controlled by nuclear factor erythroid-derived 2-like 2 (Nrf2) were strongly upregulated. 
Nrf2 is a transcriptional factor triggering oxidative stress response [156]. One of the most abundant 
Nrf2-dependent antioxidant metabolites is glutathione (GSH). GSH is required for the neutralization 
of reactive oxygen species (ROS) [157]. The glutathione-mediated detoxification pathway (Figure 
31) was highly affected in the villi of Trpm7 Intestine KO mice. Therefore, we aimed to verify 
transcriptional changes in genes of the glutathione-mediated detoxification pathway using 
qRT-PCR. 
 
 
Glutamine    Cysteine Glycine
Glutamate-cysteine ligase (Gclc)
Glutathione synthetase (Gss) 
Glutathione (GSH)
(reduced form)
Glutathione (GSSG)
(oxidized form)
Glutathione
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Excretion
Glutathione
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Glutathione reduc-
tase (Gsr)
Glutathione S-trans-
ferases (Gst)
Abcc transporters
 
Figure 31: Summary of the glutathione-mediated detoxification pathway. 
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Nrf2 regulates the expression of glutamate-cysteine ligase (Gclc) and glutathione synthetase (Gss) 
(Figure 31), two enzymes controlling glutathione synthesis [158, 159]. Both enzymes were strongly 
upregulated in Trpm7 Intestine KO mice (Figure 32 A). In addition, Nrf2 regulates expression of 
glutathione peroxidases (Gpx2) and glutathione reductase (Gsr) [160, 161]. Gpx2 reduces ROS via 
oxidation of GSH leading to the formation of GSH dimer (GSSG). Afterwards, Gsr regenerates GSH 
from GSSG. Expression of Gpx2 and Gsr was significantly increased in Trpm7 Intestine KO mice 
(Figure 32 B). 
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Figure 32: Relative expression levels of genes involved in synthesis and redox activity of glutathione 
in the villi of control and Trpm7 
Intestine KO
 mice. (A) mRNA levels of Gss and Gclc (involved in GSH 
synthesis) as well as (B) Gpx2 and Gsr (involved in redox activity of GSH) were measured using qRT-PCR 
and Hprt as a reference transcript. Values are mean ± SEM; *** - P≤0.001, * - P≤0.05 (Student’s t-test); n - 
number of mice. 
 
 
In addition, Nrf2 controls the expression of many ROS-detoxifying enzymes such as glutathione S-
transferases (Gst) catalyzing the conjunction of reactive oxidative species to glutathione [162]. 
Consistently, we found that expression of many Gsts was upregulated in Trpm7 Intestine KO mice 
(Figure 33). 
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Figure 33: Expression analysis of glutathione S-transferases (Gst) in villi of control and 
Trpm7 
Intestine KO
 mice. mRNA levels of the glutathione S-transferases (Gsta1, Gsta2, Gsta3, Gstm1, Gstm3, 
Gstp1 and mGst2) were measured using qRT-PCR and Hprt as a reference transcript. Values are mean ± 
SEM; * - P≤0.05 (Student’s t-test); n - number of mice. 
 
 
Glutathione conjugates can be excreted from the cell by Abcc transporters (Figure 31) [163], which 
were also upregulated in mutant tissue (Figure 34). Hence, we concluded that Nrf2-mediated 
oxidative stress response was triggered in villi of Trpm7 Intestine KO mice.  
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Figure 34: Expression of Abcc transporters in villi of control and Trpm7 
Intestine KO
 mice. mRNA levels of 
Abcc1 and Abcc2 were measured using qRT-PCR and Hprt as a reference transcript. Values are mean ± 
SEM; *** - P≤0.001 (Student’s t-test); n - number of mice. 
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6.4.6 Assessment of the immunological status of Trpm7 Intestine KO mice 
 
It is well documented in the scientific literature that Zn2+ deficiency negatively impacts the immune 
system [115, 164]. Accordingly, we investigated whether serum levels of interleukin 6 (IL-6), the key 
pro-inflammatory factor, were changed in Trpm7 Intestine KO mice. Using an ELISA, we determined 
that circulating levels of IL-6 were increased (11.1 times) indicating that the function of the immune 
system was indeed affected in Trpm7 Intestine KO mice. 
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Figure 35: Circulating levels of interleukin 6 (IL-6) in control and Trpm7 
Intestine KO
 mice. The 
concentration of interleukin 6 in serum of P5 control and Trpm7 
Intestine KO
 animals was measured using an 
ELISA. The results are shown as mean ± SEM; * - P≤0.05 (Student’s t-test); n - number of mice. 
 
 
Previously, the autopsy of acrodermatitis enteropathica (AE) patients suffering from a strong Zn2+ 
deficiency revealed the lack of germinal centers in the spleen and the absence of thymus [165-
167]. Moreover, these studies suggested that pneumonia or sepsis probably caused the death of 
the patients [165-167]. Further clinical studies and animal experiments could confirm that Zn2+ 
deficiency caused systemic immune deficiency [115, 164]. Consequently, we asked whether the 
morphology of immune organs was changed in Trpm7 Intestine KO mice. We examined the histological 
and macroscopic appearance of the spleen (Figure 36) and the thymus (Figure 37) in P5 
Trpm7 Intestine KO and control mice. We noted that thymus of Trpm7 Intestine KO mice was substantially 
smaller in the mutant mice (Figure 36 A, B). Interestingly, two mutant mice were completely 
athymic. Further histological analysis revealed that the medulla region was not visible in the thymus 
of Trpm7 Intestine KO mice (Figure 36 C). 
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Figure 36: Morphology of thymus of P5 control and Trpm7 
Intestine KO
 mice. Overall appearance (A), tissue 
weight normalized to body weight (B) and H&E staining of paraffin-embedded sections (C) of the thymus from 
P5 control and Trpm7 
Intestine KO
 littermates. The triangles indicate the medulla region present only in the 
thymus of control animals. Representative images are shown (n=5 tissues per genotype); ** - P≤0.01 
(Student’s t-test); n - number of mice. 
 
 
Spleen was present in all P5 Trpm7 Intestine KO mice. However, the size of the organ was significantly 
reduced (Figure 37 A, B). Interestingly, the white pulp microarchitecture was only detectable in the 
spleen of control animals. To conclude, we could show that Trpm7 Intestine KO mice develop crucial 
abnormalities in morphology and development of lymphoid organs (Figure 36, Figure 37). These 
results support the idea that similar to AE patients impaired Zn2+ homeostasis in Trpm7 Intestine KO 
mice leads to systemic immune deficiency and death of animals.  
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Figure 37: Morphology of spleen in P5 control and Trpm7 
Intestine KO
 mice. Overall appearance (A), tissue 
weight normalized to body weight (B) and H&E staining of paraffin-embedded sections (C) of the spleen from 
P5 control and Trpm7 
Intestine KO
 littermates. The stars indicate the white pulp observed only in control organs. 
Representative images are shown (n=5 tissues per genotype); ** - P≤0.01 (Student’s t-test); n - number of 
mice. 
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6.5 Assessment of TRPM7’s kinase function on organismal mineral homeostasis 
 
As TRPM7 comprises a channel and a protein kinase moiety, we asked whether the lack of kinase 
activity may play a role in the deficiency of divalent cations in Trpm7 Intestine KO mice. We examined a 
kinase-dead mouse strain carrying a point mutation in its catalytic site (Figure 10, Table 46). This 
line was previously reported by Kaitsuka and colleagues [65]. In our study, we crossed females and 
males heterozygous for the kinase-dead mutation and used Trpm7 ki/ki (KI) and Trpm7 wt/wt (control) 
littermates for a follow-up phenotypic analysis. For genotyping of Trpm7 ki/ki, Trpm7 ki/wt and 
Trpm7 wt/wt offspring, we used PCR primers flanking the DNA sequence containing the point 
mutation. The corresponding PCR produces a 205 bp product for both wt and ki allele. However, 
the sequence of the wt allele contains a recognition sequence of the Tru1I restriction enzyme 
(T/TAA). Exchange of T by C (C/TAA) in K1646R TRPM7 variant destroys this sequence motif. 
Consequently, Tru1I was used to probe wt vs ki sequence in PCR amplicon as outlined in Figure 
38. 
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Figure 38: Genotyping of Trpm7 
ki/ki
, Trpm7 
ki/wt
 and Trpm7 
wt/wt
 mice. Genomic DNA obtained from tail 
fragments of Trpm7 
ki/ki
, Trpm7 
ki/wt
 and Trpm7 
wt/wt
 mice was analyzed by PCR approach using primers 
specific for the region carrying the point mutation. Amplicons were treated with the restriction enzyme Tru1I. 
The PCR amplicons (205 bp for Trpm7 
ki
; 120 and 85 bp for Trpm7 
wt
) were examined using agarose gel 
electrophoresis. H2O was used to verify the specificity of PCR. 
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In line with previous reports [43, 64, 65], Trpm7 ki/ki mice displayed a normal physical appearance, 
unchanged body weight (Figure 39 A) and no sign of early mortality (Figure 39 B). In addition, 
genotyping of offspring resulted in the expected Mendelian inheritance of the KI alleles (Table 46). 
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Figure 39: Body weight and survival rate of Trpm7 
wt/wt
 (control) and Trpm7 
ki/ki
 (KI) mice. (A) Body 
weight of 8 weeks old Trpm7 
wt/wt
 (control) and Trpm7 
ki/ki
 (KI) mice. (B) Trpm7 
ki/ki
 mutation did not induce 
mortality in the mutant mice during 8 weeks of the postnatal life. Values are mean ± SEM; n.s. - not 
significantly different (Student’s t-test); n - number of mice. 
 
 
Next, we investigated the mineral content in serum and bones of 8 weeks old Trpm7 wt/wt and 
Trpm7 ki/ki littermates using ICP-MS. Mg and Zn concentrations were not altered (Figure 40), 
whereas Ca levels were modestly elevated in serum but were normal in bones (Figure 40 A, B). 
These findings suggest that the lack of TRPM7 channel, but not kinase activity, triggers the 
phenotype of Trpm7 Intestine KO mice. 
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Figure 40: Assessment of divalent cation levels in serum and bones of Trpm7 
wt/wt
 (control) and 
Trpm7 
ki/ki
 (KI) mice. Levels of Ca (left panel), Mg (middle panel) and Zn (right panel) were examined in 
serum (A) and bones (right tibia) (B) in 8 weeks old control and KI mice using ICP-MS. Values are mean ± 
SEM; * - P≤0.05 (Student’s t-test), n.s. - not significantly different; n - number of mice. 
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7 Discussion 
 
7.1 TRPM7 regulates the cellular contents of Zn2+ and Mg2+ 
 
Independent studies have shown that the TRPM7 channel is a constitutively active channel, which 
is highly permeable to divalent cations with the permeability sequence Zn2+ > Mg2+ ≥ Ca2+ [6, 13, 14, 
168-171]. However, these patch-clamp experiments were performed using TRPM7 transfected cells 
exposed to extracellular solutions with very high levels of individual cations (10-20 mM or 120 mM) 
and complete removal of intracellular divalent cations. Therefore, the particular cellular function of 
the native TRPM7 channel under physiological conditions remains incompletely understood [6, 17, 
43, 44]. For instance, the role of TRPM7 in the cellular balance of Mg2+ vs Ca2+ is discussed 
controversially in the field [17, 59]. In addition, it is difficult to estimate whether endogenous TRPM7 
is capable to regulate the influx of Zn2+ under a ~100-fold excess of Mg2+ and Ca2+. 
In order to clarify these issues, we explored a HAP1 cell line carrying a loss-of-function mutation in 
TRPM7 introduced by the CRISPR/Cas9 approach [44]. We cultured HAP1 cells in a medium 
containing physiological levels of extracellular Zn2+, Ca2+ and Mg2+ and analyzed elementary 
contents of divalent and monovalent cations using ICP-MS. We could show that the total level of 
Zn2+ was decreased in HAP1 cells and that Zn2+ deficiency can be compensated by the addition of 
exogenous Zn2+ to the cell culture medium. In follow-up experiments, we examined the ability of 
TRPM7 to regulate the uptake of the radioactive zinc isotope 65Zn2+ in HAP1 cells exposed to saline 
containing physiological levels of extracellular Mg2+, Ca2+ and Zn2+. We demonstrated that TRPM7-
deficient HAP1 cells displayed diminished 65Zn2+ influx. Hence, the preference of the TRPM7 
channel pore for Zn2+ correlates with the nonredundant role of TRPM7 in maintaining the cellular 
balance of Zn2+. 
In line with previous studies [6, 17, 43, 44], we observed that the lack of TRPM7 leads to 
decreased content of elementary Mg2+ in HAP1 cells. However, we found that total cellular 
concentrations of Ca2+ and monovalent cations were not affected in TRPM7-deficient HAP1 cells. 
Taken together, our experiments revealed that the TRPM7 channel is required for cellular uptake of 
Zn2+ and Mg2+ in the cell. Accordingly, we propose that a particular cellular response to the 
inactivation of TRPM7 will depend on (i) the actual metabolic demand of the cell for an individual 
cation and (ii) expression of other channels/transporters within the cell. 
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7.2 TRPM7 is redundant for renal handling of Ca2+, Zn2+ and Mg2+ 
 
Previously, it was reported that the expression level of Trpm7 is high in the kidney compared to 
other organs [145], suggesting that TRPM7 may play a critical role in renal handling of Mg2+, Ca2+ 
and Zn2+. While a role of the kidney in reabsorption of Zn2+ remains unknown, the systemic 
homeostasis of Mg2+ and Ca2+ was thought to rely on a transcellular transport of these cations in 
the DCT nephron segment [76, 86, 141]. Using in situ hybridization (ISH), we could show that 
Trpm7 is highly expressed in nephron segments resembling DCT. In line with these results, high 
expression levels of Trpm7 were observed in two other recent studies [143]. Our examination of 
Trpm7 Kidney KO mice confirmed an efficient deletion of Trpm7 transcripts in the DCT. Surprisingly, we 
found no detectable changes in physical appearance or behavior of mutant mice as well as serum 
levels and urinary excretion rates of Ca2+, Zn2+ or Mg2+. These findings argue that TRPM7 is 
functionally redundant in the DCT. 
 
 
7.3 Intestinal TRPM7 is essential for postnatal growth and survival of mice  
 
To gain insight whether TRPM7 is necessary for intestinal uptake of divalent cations, we explored 
Villin1-Cre transgene enabling to induce inactivation of TRPM7 specifically in the enterocytes of the 
whole intestine in Trpm7 fl/fl mice [59, 134]. On the contrary to the Trpm7 Kidney KO mice, intestine-
specific deletion of TRPM7 had a strong impact on the postnatal development of Trpm7 Intestine KO 
mice. The mutants were born in the expected ratio and were indistinguishable from control 
littermates at P1. However, Trpm7 Intestine KO mice nearly stopped to grow at P3–5. Furthermore, P3–
P5 Trpm7 Intestine KO pups displayed a very high mortality rate and all mutants died after P10.  
Consequently, we asked whether the lack of intestinal TRPM7 could affect morphogenesis of the 
gut resulting in nutritional malabsorption of newborn mice. To this end, we performed an extensive 
assessment of P1–P5 littermates to establish whether intestinal deletion of TRPM7 induced 
negative effects on the macroscopic or histological appearance of the intestine, tissue homeostasis 
and overall transcriptional profile of the intestine. Specifically, we found that the stomach of 
Trpm7 Intestine KO pups was filled with milk, suggesting that the feeding behavior of the mutants was 
normal. We noted that the length of the whole intestine was identical in Trpm7 Intestine KO pups and 
control mice. Histological examination of the small and large intestine isolated from Trpm7 Intestine KO 
individuals at P1 did not show remarkable abnormalities of mucosal or villi architecture indicating 
unaffected intestinal organogenesis. In addition, we extracted RNA from the whole duodenum of P5 
control and mutant littermates and investigated the expression levels of transcriptional markers of 
tuft cells, enterocytes, intestinal stem cells, Paneth cells and goblet cells. We found that, except the 
Paneth cell marker, the expression levels of these transcripts were not altered suggesting that the 
deletion of TRPM7 did not impact the development of major types of intestinal epithelial cells.  
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Finally, we used an unbiased strategy to examine villus cell homeostasis in Trpm7 Intestine KO mice: 
we extracted RNA from villi isolated from the whole intestine of P5 littermates and performed 
genome-wide transcriptome profiling. We found that inactivation of Trpm7 affected primarily 
transcriptional networks controlling glutathione-mediated detoxification, Nrf2-mediated oxidative 
stress response, cholesterol biosynthesis and xenobiotic metabolism. It is well documented, that 
abnormal Zn2+ and Mg2+ balance can elicit oxidative stress [42, 172]. For instance, genetic 
inactivation of Trpm6 in mice leads to systemic Mg2+ deficiency associated with an induction of 
gene networks controlling oxidative stress in the liver [44]. Interestingly, oxidative stress has also 
been linked to TRPM7 in cultured neurons and other cell types [48, 173].  
Oxidative stress is a metabolic disturbance that is followed by the oxidation of biomolecules, 
resulting in oxidative damage of cells and tissues [172]. The transcriptional regulator Nrf2 controls 
the expression of enzymes involved in the glutathione (GSH) dependent neutralization of reactive 
oxygen species (ROS) [156, 174]. Accordingly, we conducted additional experiments to elucidate 
expression levels of 18 Nrf2-dependent transcripts involved in the metabolism of GSH and found 
that these transcripts are highly upregulated in the intestine of P5 mutants. Altogether, we 
concluded that the intestine specific deletion of Trpm7 did not affect the morphogenesis and tissue 
homeostasis of the intestine, but rather engenders postnatal metabolic deficits associated with 
oxidative stress. 
A systemic deficiency of Zn2+, Mg2+ or Ca2+ is frequently accompanied by growth failure and even 
death of mice [44, 107, 131]. Therefore, we studied whether diminished uptake of divalent cations 
has underlain the striking phenotypes of Trpm7 Intestine KO animals. In line with macroscopic 
appearance of P1 Trpm7 Intestine KO mice, we found no significant changes in Zn2+, Ca2+ or Mg2+ 
levels in serum and bones at P1, indicating that newborn Trpm7 Intestine KO mice had normal 
nutritional intake of these minerals. At P3, circulating levels of Zn2+ and Ca2+ were decreased in 
bones. Most notably, P5 mutants displayed very low levels of Zn2+, Ca2+ and Mg2+ in serum. In P5 
bones we found a similar pattern: Zn2+ and Ca2+ concentrations were significantly reduced, while 
Mg2+ contents were normal. Importantly, levels of the monovalent cations (Na+ and K+) were nearly 
identical in P1–5 Trpm7 Intestine KO and control animals.  
Accordingly  based on our findings we offer a new concept resolving a ‘paradox’ of TRPM7 
functioning either as a Ca2+ or Mg2+ or Zn2+ permeable ion channel in epithelial cells. We propose 
that TRPM7 functions as a common gatekeeper regulating the bulk nutritional uptake of essential 
divalent metals, and not specific to only one. 
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7.3.1 Emerging role of the TRPM7 channel in Zn2+ homeostasis 
 
A key finding of the present study is that the TRPM7 channel regulates cellular Zn2+ levels and that 
such function appears to correlate with the in vivo role of TRPM7 in intestinal uptake of this cation. 
It is well established that the small intestine controls whole-body Zn2+ balance by adjusting 
absorption and excretion rates of Zn2+, whereas a role of the kidney in systemic Zn2+ homeostasis 
is considered as minor [117, 118].  
Mechanistically, nutritional intake of Zn2+ remains poorly understood. Two large families of Zn2+ 
transporters are thought to be involved in such processes. 10 ZnT transporters (ZnT1-10, also 
known as Slc30a1-10) were suggested to regulate efflux of cytoplasmic Zn2+ to extracellular space 
or uptake of cytosolic Zn2+ in intracellular vesicles serving as Zn2+ stores [115]. In contrast, 14 Zip 
transporters (Zip1-14 or Slc39a1-14) increase cytoplasmic Zn2+ levels by facilitating extracellular 
and vesicular Zn2+ transport in the cytoplasm [115]. Many ZnT and Zip proteins were found to be 
expressed in the small intestine [115]. However, with a few exceptions (discussed below), genetic 
animal models failed to demonstrate a particular role of ZnT and Zip proteins in Zn2+ nutrition, 
possibly because of their functional redundancy.  
Spontaneous mutations in the murine ZnT4 gene, which is expressed in mammary glands and 
intestine [147, 175]  result in the “lethal milk” phenotype [175]. The key characteristic of the “lethal 
milk” syndrome is a ~35% decreased concentration of Zn2+ in breast milk of mutant dams [176] 
causing 100% death of suckled offspring within 10 days of postnatal life [155]. When pups 
homozygous for ZnT4 mutation are suckled by wt foster mothers, they develop normally [176]. 
Adult ZnT4-deficient mice develop a mild form of Zn2+ deficiency [177]. It was proposed that ZnT4 
is located on the basolateral cell surface of epithelial cells to regulate Zn2+ efflux in the bloodstream 
or breast milk [177]. As serum Zn2+ concentrations in Trpm7-deficient mice were only 39% of 
control values at P5, it is to be expected that the early postnatal mortality of Trpm7-deficient mice is 
similar to the “lethal milk” genetic model. 
Unlike to ZnT4, Zip4 is primarily expressed in the small intestine and is located to the apical surface 
of enterocytes [122, 123, 178, 179]. Mutations in the human ZIP4 gene result in the genetic 
syndrome “acrodermatitis enteropathica” (AE) caused by a disturbed intestinal Zn2+ absorption 
[122, 128, 129]. A mouse model with a deletion of Zip4 specifically in the epithelial cells of the 
intestine (Zip4 intestine KO) was generated to verify this function [131]. Similar to human AE 
patients, Zip4-deficient animals develop normally until weaning because breast milk is particularly 
enriched in Zn2+. However, adult mutants develop a fatal Zn2+ deficiency. Zip4-deficient animals are 
characterized by a rapid loss of weight. The mortality of Zip4-deficient animals is rescued by an 
excess of Zn2+ in the drinking water. Since Zip4 intestine KO mice develop symptoms only after 
weaning it was speculated that there is an additional route for intestinal Zn2+ uptake [133], likely by 
TRPM7. MT1 is the main intracellular scavenger of Zn2+, which is transcriptionally regulated by Zn2+ 
availability [124, 125]. Interestingly, Zip4 intestine KO and ZnT4 KO mice show a strong 
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upregulation of intestinal MT1 [131, 177]. We observed a similar pattern: MT1 was significantly 
upregulated in Trpm7 Intestine KO animals. Expression of metallothioneins can also be induced by 
oxidative stress [180]. We found that gene networks of oxidative stress were enhanced in the villi of 
Trpm7 Intestine KO mice. Hence, the upregulation of MT1 in epithelial cells of Trpm7 Intestine KO mice may 
be caused by oxidative stress and/or impaired Zn2+ balance. In addition, consistently with previous 
studies [131, 177], we found that mRNA levels of ZnT1, ZnT2, Zip4 and Zip5 were significantly 
downregulated in tissues of Trpm7 Intestine KO animals. 
A particular link between insufficient nutritional intake of Zn2+ and death has not yet been 
established for the deadly-milk ZnT4-deficient strain. Looking for such a link in Trpm7 Intestine KO 
mice, we resorted to the pioneering autopsy of AE patients, which revealed the absence of thymus 
and the lack of germinal centers in the spleen. Pneumonia or sepsis was likely causing the death of 
these patients [165-167]. Follow-up clinical studies and experiments with animal models have 
fostered the commonly accepted view that organismal Zn2+ deficiency leads to a systemic decline 
of innate and adaptive immune response [115, 164]. Consequently, we examined the macroscopic 
and histological appearance of thymus and spleen in Trpm7 Intestine KO mice. Notably, two mutant 
mice were athymic, while the remaining Trpm7 Intestine KO mice had only rudimentary organs. Spleen 
was present in all mutant mice, but the size of the organ was substantially reduced. Histological 
analysis revealed that Trpm7 Intestine KO mice develop grave abnormalities in the morphology of 
lymphoid organs. Thus, the medulla region was not visible in the thymus of mutant mice. In the 
spleen of Trpm7 Intestine KO mice, the white pulp microarchitecture was not detectable. Based on 
these findings we propose that Trpm7 Intestine KO mice develop immune deficiency incompatible with 
organismal survival. In line with this idea, we observed that Trpm7 Intestine KO mice display remarkably 
high circulating levels of the pro-inflammatory cytokine IL-6. 
Finally, we demonstrated that high Zn2+ diets of breeding dams significantly improved the survival 
of Trpm7 Intestine KO mice (particularly at the onset of mortality, P3–5). Furthermore, in contrast to the 
situation with the untreated group of Trpm7 Intestine KO mice, the Zn2+-enriched diet allowed two 
mutants to survive until weaning. Furthermore, we examined the survival rate of mutant pups from 
females maintained on a combined diet enriched in Ca2+, Mg2+ and Zn2+ and found that the survival 
distribution of this group closely resembles that of the group receiving a high Zn2+ diet, suggesting 
that Zn2+ deficiency in Trpm7-deficient mice plays the predominant role in early mortality. As 
discussed above, such an outcome is not unexpected, because new-born rodents are highly 
sensitive to insufficient intake of Zn2+. It should also be noted that in contrast to a classical genetic 
approach when the mutant locus is complemented by a functional variant of the gene, the efficiency 
of nutritional Zn2+ fortification in our experimental setting is limited by (i) the ability of nursing 
females to increase Zn2+ in milk and (ii) the capability of other intestinal transporters to compensate 
for the lack of TRPM7. Therefore, a complete rescue of the mortality of Trpm7-deficient mice 
cannot be expected realistically. Taken together, these results are well consistent with the 
suggested role of TRPM7 as a gatekeeper of nutritional intake of Zn2+. 
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7.3.2 Intestinal TRPM7 as a new player in organismal Ca2+ balance 
 
Early studies revealed that body balance of Ca2+ is maintained by intestinal uptake and renal reab-
sorption of Ca2+ primarily via a transcellular route consisting of apical entry and basolateral extru-
sion of Ca2+. Historically, Ca2+-selective channels are thought to underlie the apical Ca2+ entry. 
Thus, the Ca2+-selective TRPV6 channel was proposed to operate as a major player in intestinal 
Ca2+ uptake, and TRPV5 was proposed as a gatekeeper of renal reabsorption of Ca2+. However, 
Trpv5 and Trpv6 null mice did not display a significant reduction of serum Ca2+ levels. Furthermore, 
Trpv6 null mice showed only modestly diminished [107] or even unchanged intestinal Ca2+ absorp-
tion [113, 114] suggesting that additional absorption pathways play a role. 
In the present study, we show that mice with an intestinal deletion of TRPM7 display a severe Ca2+ 
deficiency at early postnatal stages. Specifically, mutant P5 pups displayed a strong decrease in 
Ca2+ concentrations in both serum and bones, increased serum concentrations of PTH (18.2-fold) 
and 1,25-(OH)2D3 (9.4-fold) as well as a strong upregulation of Cyp27b1, Trpv6 and Calbindin-D9k 
transcripts. These findings suggest that TRPM7, rather than TRPV5 or TRPV6, represents the in-
dispensable mechanism controlling the systemic intestinal Ca2+ balance.  
 
 
7.3.3 A new role of TRPM7 in systemic Mg2+ homeostasis  
 
Mg2+ is required for many biologic processes [42]. More than 20 membrane Mg2+ 
channels/transporters have been suggested. However, their precise function remains not well 
understood. The kinase-channel TRPM6 is the closest homologue of TRPM7. Recently, our group 
has demonstrated that mice with a global deletion of Trpm6 (Trpm6 KO) develop a severe 
organismal deficiency in Mg2+ [44]. Breastfed Trpm6 null pups developed normally. In contrast, 8 
weeks old Trpm6 KO animals displayed a strong depletion of Mg2+ in bones and significant 
reduction of serum Mg2+ levels due to a defective intestinal uptake of Mg2+ [44]. Soon after 
weaning, Trpm6 KO animals showed a high mortality rate. Moreover, intestine-restricted 
inactivation of Trpm6 induced a more moderate Mg2+ deficiency suggesting that WT kidneys were 
not capable of compensating for the lack of intestinal TRPM6. These results supported the concept 
that intestinal TRPM6 is critically involved in Mg2+ homeostasis in adult mice.  
TRPM7 has already been linked to intestinal Mg2+ uptake in studies with mice heterozygous for a 
global Δkinase mutation truncating TRPM7 prior to the kinase domain (Trpm7 Δkinase/wt mice) [43]. 
Trpm7 Δkinase/wt mice were asymptomatic if maintained on a standard animal chow. Fed by a low 
Mg2+ diet, the mutant mice showed decreased Mg2+ levels in plasma and bones, an elevated fecal 
Mg2+ content and an increased mortality rate as compared to control mice. The authors concluded 
that Trpm7 Δkinase/wt mice develop a defect in intestinal Mg2+ absorption. However, the biological 
relevance of these findings is not clear since maintaining of animals using a low Mg2+ diet is a very 
   7 Discussion 
  
96 
unphysiological challenge. 
In the present work, we demonstrated that intestine-restricted ablation of TRPM7 is sufficient to 
induce systemic Mg2+ deficiency in new-born mice in conjunction with lowered serum levels of IGF1 
(a suggested marker of Mg2+ deficiency [181]) and upregulated expression of intestinal Trpm6 
(~30-fold) as well as the putative Mg2+ transporters Slc41a1 and Slc41a2. In line with these 
findings, we observed that dietary Mg2+ supplementation was beneficial for the survival of 
Trpm7 Intestine KO mice. Overall, our results indicate that whole-body balance of Mg2+ depends on the 
intestinal TRPM7 channel. 
 
 
7.4 The TRPM7 kinase activity is dispensable for the organismal balance of divalent cations 
 
Our genetic strategy for conditional deletion of TRPM7 leads to the elimination of both the channel 
and kinase activities of TRPM7. Consequently, the severe phenotype of Trpm7 Intestine KO mice can 
be, at least in part, caused by the lack of TRPM7 kinase activity. In vitro studies with recombinant 
TRPM7 produced controversial results regarding the role of TRPM7 kinase in regulation of the 
channel function. Several publications reported that the kinase activity modulates TRPM7 currents 
[14, 17, 182], while other studies suggested that TRPM7 kinase has a low impact on the TRPM7 
channel [33]. 
To investigate the physiological role of TRPM7 kinase, two independent groups (Kaitsuka et al. and 
Ryazanova et al.) generated mice strains carrying a constitutive kinase-dead K1646R mutation in 
Trpm7 (Trpm7 ki/ki) [65, 66]. Kaitsuka et al. revealed that the mutant mice exhibited a normal 
development and unchanged Mg2+ and Ca2+ serum concentrations [65]. In another publication, 
Ryazanova et al. [66] also reported that kinase-dead mice developed normally. However, 6 months 
old mutants displayed reduced Mg2+ content in bones (15%) without remarkable changes of Mg2+ 
levels in serum. Thus, both studies suggested that TRPM7 kinase has a low (if any) impact on the 
systemic balance of divalent cations. As Kaitsuka et al. and Ryazanova et al. did not attempt to 
investigate Zn2+ homeostasis in kinase-dead TRPM7 mice, we re-examined 8-10 weeks old 
mutants in our experimental settings. Our experiments did not reveal significant alterations in body 
balance of divalent cations. We concluded that the phenotype of mice with an intestine-restricted 
null mutation of Trpm7 was primarily triggered by the lack of the channel activity of TRPM7. 
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8 Conclusions 
 
The present study aimed to define the physiological role of the channel-kinase TRPM7 by 
assessment of TRPM7-deficient cells and phenotyping of mouse strains with organ-restricted null 
mutations in Trpm7. Specifically, the obtained results support the following conclusions: 
 
1. In resting cells, endogenous TRPM7 regulates the influx of Zn2+ and Mg2+. Consequently, 
deletion of TRPM7 results in a reduced cellular content of Mg2+ and Zn2+. 
 
2. Conditional disruption of renal Trpm7 has no effect on mineral homeostasis and postnatal 
development of mice. 
 
3. Conditional mutagenesis of intestinal Trpm7 in mice did not affect embryonic 
morphogenesis of the gut but triggers postnatal metabolic deficits associated with oxidative 
stress and immunodeficiency due to disrupted Zn2+, Mg2+ and Ca2+ homeostasis, a scenario 
incompatible with early postnatal growth and survival. Dietary Zn2+ and Mg2+ fortifications 
significantly extended the survival of mutants. 
 
4. Global ablation of TRPM7 kinase activity in mice did not affect organismal homeostasis of 
divalent cations, reinforcing the importance of the channel activity of TRPM7. 
 
Taken together, these findings support the concept that the organismal balance of Zn2+, Mg2+ and 
Ca2+ critically relies on one common gatekeeper, the TRPM7 channel. 
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Abcc1 ATP-binding cassette C1 
Abcc2 ATP-binding cassette C2 
ATP adenosine triphosphate 
  
bp base pair 
BSA bovine serum albumin 
  
Ca calcium 
Cas CRISPR-associated 
CRISPR  clustered regularly interspaced short palindromic repeats 
Cyp27b1 cytochrome p450 27b1 
  
d day 
Dclk1 doublecortin like kinase 1 
DCT distal convoluted tubule 
DIG digoxigenin 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
dpm disintegrations per minute 
DTT dithiothreitol 
  
ELISA enzyme-linked immunosorbent assay 
EtOH ethanol 
  
FBS fetal bovine serum 
fl floxed 
  
g gram 
Gclc glutamate cysteine ligase catalytic subunit 
Gpx2 glutathione peroxidase 2 
Gsr glutathione reductase 
Gss glutathione synthetase 
Gsta1 glutathione S-transferase alpha 1 
Gsta2 glutathione S-transferase alpha 2 
Gsta3 glutathione S-transferase alpha 3 
Gstp1 glutathione S-transferase P1 
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h hour 
H&E hematoxylin and eosin 
HAP1 human haploid leukemia 
Hprt hypoxanthine-guanine phosphoribosyl transferase 
  
ICP-MS inductively coupled plasma mass spectrometry 
IGF1 insulin-like growth factor 1 
IL-6 interleukin 6 
IMDM Iscove’s Modified Dulbecco’s Medium 
  
K thymine 
ki knock in 
KO knock out 
  
l liter 
Lgr5 leucine-rich repeat-containing G-protein coupled receptor 5 
Lyz1 lysozyme 1 
  
m milli 
M molar 
Mg magnesium 
Mgst2 microsomal glutathione S-transferase 2 
min minute 
MT1 metallothionein 1 
Muc2 mucin 2 
  
P phosphorus 
P1 postnatal day 1 
P3 postnatal day 3 
P5 postnatal day 5 
P21 postnatal day 21 
P23 postnatal day 23 
P33 postnatal day 33 
P37 postnatal day 37 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PTH parathyroid hormone 
  
qRT-PCR quantitative real-time PCR 
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R cytosine 
RNA ribonucleic acid 
rpm revolutions per minute 
  
s second 
S sulfur 
SEM standard error of the mean 
Slc41a1 solute carrier family 41 member 1 
Slc41a2 solute carrier family 41 member 2 
  
T4 thyroxine 
tRNA transfer RNA 
Trpm6 transient receptor potential cation channel, subfamily M, member 6 
Trpm7 transient receptor potential cation channel, subfamily M, member 7 
Trpv5 transient receptor potential cation channel, subfamily V, member 5 
Trpv6 transient receptor potential cation channel, subfamily V, member 6 
  
U unit 
  
V volume 
  
wt wildtype 
  
Ywhaz tyrosine 3/5 monooxygenase 
  
Zip4 solute carrier family 39 member 4 
Zip5 solute carrier family 39 member 5 
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